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Cocaine abuse is an important social health concern of people around the world. 
Cocaine has the second highest level of dependence among all illicit drugs in 2006 
(Marijuana was the most abused drug) and has accounted for more emergency room visits 
than any other illegal drug in United States (CEWG 2006; DAWN 2004). In the United 
States, among people aged 12 or older, around 6 million people used cocaine and the 
average age of onset of cocaine use was 20 in 2006 according to the National Surveys on 
Drug Use and Health (SAMHSA 2007). Problems associated with cocaine addiction 
range from psychological and physical health problems to social problems including HIV 
infection, AIDS and associated crimes. In the last decade, extensive research has been 
conducted to understand the neural mechanisms underlying cocaine use and cocaine 
addiction. The ascending midbrain dopamine (DA) system, in particular, plays a critical 
role in mediating the effects of cocaine, and neuroadaptations of this system with chronic 
cocaine use have been suggested to contribute to cocaine addiction (Thomas et al. 2008).  
Over the last thirty years, the patterns of cocaine use differ between men and women 
(Wetherington 2007). Clinical studies suggest a role of ovarian hormones in modulating 
subjective response to cocaine in humans (Evans 2007). Both intrinsic sex differences 
that are independent of gonadal hormones, as well as sex differences that are induced by 
ovarian hormones contribute to sex differences in the effects of cocaine as shown in 
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preclinical studies (Becker and Hu 2008; Lynch et al. 2002). This dissertation is designed 
to further characterize the effect of ovarian hormones on long term effects of cocaine. 
Additionally, an effort has been made to understand how the DA system is influenced by 
sex or hormones to mediate the differences in cocaine-induced responses. Even though 
the effect of cocaine is the major focus of this dissertation, cocaine and amphetamine 
(AMPH) are psychostimulants that produce very similar effects through similar 
mechanisms. Therefore, this background discussion is based on current preclinical and 
clinical studies with psychostimulant drugs that include both cocaine and AMPH. 
First, I will review the effect of cocaine and AMPH on the central nervous system 
(CNS) and discuss the role of DA in cocaine-related effects based on preclinical studies 
and human imaging studies. Second, I will review evidence demonstrating sex 
differences in psychostimulant-related effects in both humans and animals, which 
suggests that females are more vulnerable than males to the effect of cocaine and AMPH. 
The differences are due to both intrinsic sex differences independent of gonadal 
hormones and effects of gonadal hormones on a sexually dimorphic brain. Finally, the 
influences of sex and hormones in the brain, in particular the midbrain dopaminergic 
system, will be discussed in relation to the neural mechanism that may be mediating sex 
differences in response to psychostimulants. This introduction will conclude with the 
working hypothesis and specific aims of the studies that comprise the dissertation. 
1. Neural mechanisms mediating effects of cocaine and AMPH 
1.1 Effects of cocaine and AMPH in humans 
Cocaine and AMPH are potent psychomotor stimulant drugs. At low doses, they 
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enhance hyperactivity, alertness, concentration, restlessness, motivation to work, self-
confidence, sexual interest and pleasure, and feelings of well being, and reduce social 
inhibition and anxiety (Fischman and Schuster 1980; Gold 1984; Swerdlow et al. 1986). 
In the peripheral nervous system, they cause an increase in heart rate (Evans et al. 2002; 
Knuepfer and Branch 1992), blood pressure (Kollins and Rush 2002; Sofuoglu et al. 
2001), and respiratory rate (Foltin et al. 2003; Javaid et al. 1978). With higher doses, the 
drugs can produce itching, tachycardia, hallucinations, and paranoid delusions. Overdose 
produces a life-threatening elevation of blood pressure and hyperthermia (Callaway and 
Clark 1994; Sulzer et al. 2005).  
With repeated use of cocaine, episodic and prolonged binge patterns of cocaine use 
often occur. During the binge use of cocaine, users experience intense and extreme 
euphoria and often develop uncontrolled dosage escalation or switch to rapid and higher 
intensity administration routes such as smoking or intravenous administration. 
Immediately following such a cocaine binge, the user suffers from severe depressive 
symptoms mixed with irritability, anxiety and cocaine craving, which is called a “crash”. 
Anhedonia emerges after a crash, and is the major characteristic of the withdrawal phase. 
This anhedonic dysphoria often induces severe cocaine cravings and results in further 
cocaine binges, especially when they are presented with a conditioned cue. Abstinence 
occurs when addicts have resolved the withdrawal anhedonia. In this stage, conditioned 
cocaine craving can recure even years after the last cocaine use, which often results in 
relapse. Unlike other addictive drugs, such as alcohol and opiates, cocaine produces no 
severe physiological withdrawal symptoms (Gawin 1991).  
Similarly, addiction to AMPH is also associated with tolerance to the medication, 
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withdrawal symptoms, such as excessive sleeping, increased appetite, depression, anxiety 
and craving. Heavy use of AMPH often leads to psychosis that includes hallucinations, 
behavioral disorganization and delusions. With the increasing use of AMPH, the 
incidence of psychotic reaction to this drug is growing. Finally, this psychotic reaction 
may undergo spontaneous recurrences known as “flashbacks” even when the users have 
been abstinent from the drug for a very long period (Ellinwood et al. 2000; Meyer and 
Quenzer 2005a).   
In the clinic, cocaine is a topical anesthetic used in eye, throat and nose surgery. 
AMPH is commonly used to treat attention-deficit hyperactivity disorder (ADHD) in 
adults and children, the daytime drowsiness symptoms of narcolepsy and chronic fatigue 
syndrome (Ellinwood et al. 2000; Meyer and Quenzer 2005a). 
Since psychostimulants do not produce severe physiological withdrawal symptoms, 
subjective experiences or symptoms other than physiological discomfort are thought to be 
crucial in psychostimulant addiction (Gawin 1991). Thus, understanding the effect of 
psychostimulants in the brain is of particular interest to us and will be reviewed below. 
1.2 Basic function of psychomotor stimulants  
Cocaine (Figure 1.1) is a crystalline tropane alkaloid and was first derived from the 
coca plant and related species. Now lots of synthesized cocainelike drug are available. It 
acts primarily as an inhibitor of monoamine (DA, serotonin and norepinephrine) uptake 
transporters. It binds to transporter proteins, blocks the reuptake of monoamines, and 
results in accumulation of monoamines in the extracellular space (Meyer and Quenzer 
2005b). Cocaine can also block voltage-gated sodium channels to produce local 
anesthetic effects (Yasuda et al. 1984). 
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Cocaine (C17H21NO4)             AMPH (C9H13N) 
Figure 1.1 Chemical structure of cocaine and AMPH 
 
AMPH (Figure 1.1) was first synthesized in 1887 by Lazar Edeleanu at the 
University of Berlin. Unlike cocaine, AMPH binds to transporter proteins and is 
subsequently transported into the cytoplasm of the nerve terminal, resulting in increasing 
cytoplasmic levels of monoamines by interfering with vesicular storage. The increased 
cytoplasmic concentration of monoamines and the direct action of monoamine on 
transporter leads to the reversal of the transporter and monoamine efflux from the 
intracellular to the extracellular space (Howell and Kimmel 2008; Sulzer et al. 2005).  
1.3 Neuroanatomy of ascending midbrain DA system 
Even though cocaine and AMPH influence DA, serotonin and norepinephrine 
neurotransmission in the brain, the psychostimulant and reinforcing properties of those 
drugs have been thought to be mediated mainly through DA. Thus, for the convenience of 
the discussion that follows, the ascending midbrain DA system will be briefly reviewed 
below. 
Most DA neurons in the brain originate from the ventral tegmental area (VTA) and 
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substantia nigra pars compacta (SNc). VTA DA neurons mainly project to the limbic 
cortex (prefrontal cortex, orbitofrontal cortex, anterior cingulate) and other limbic 
structures (such as ventral pallidum, amygdala, hippocampus, nucleus accumbens), which 
have been termed mesocortical and mesolimbic DA systems, respectively. The 
mesocorticolimbic system has been extensively studied for its role in the rewarding 
properties of both natural stimuli and addictive drugs (Wise 1996). The dopaminergic 
projection from SNc to the striatum is called nigrostriatal DA system. This pathway is a 
major part of basal ganglia and plays an important role in the coordination of motor 
activity. Degeneration of nigrostriatal DA neurons leads to Parkinson’s disease 
(Hornykiewicz 2001). 
Approximately 90% of the neurons in the nucleus accumbens (NAc) and striatum 
are medium spiny GABAergic neurons. In addition to DA projections, striatum also 
receives glutamatergic inputs from the neocortex and thalamus while NAc receives 
glutamatergic inputs mainly from the amygdala, hippocampus, prefrontal cortex and 
thalamus (Sesack et al. 2003; Smith and Bolam 1990; Smith et al. 2004). The 
glutamatergic inputs play an important role in addiction (Kalivas et al. 2005; Wolf 1998).  
1.4 DA and locomotor stimulating and reinforcing effects of psychostimulants 
Several animal behavioral models, such as conditioned place preference, rotational 
behavior, locomotor activity, stereotypy, sensitization and self-administration, have been 
widely used to examine and understand the neural mechanisms mediating the effects of 
psychostimulants. The following section will review the current understanding of neural 
mechanism mediating the acute response to psychomotor stimulants and the reinforcing 
effects of cocaine and AMPH based on preclinical studies. 
 7
DA and psychomotor stimulating effect 
Relevant to the hyperactivity produced in humans, psychostimulants also produce 
behavioral activating effects in animals. Psychostimulant-induced hyperactivity is often 
evaluated by quantifying locomotion, stereotypy, or rotational behavior exhibited by 
animals. After an acute injection of a low dose of cocaine or AMPH, animals will show a 
profound increase in locomotor activity or rotational behavior (another indication of 
locomotor activation due to endogenous- or lesion produced- imbalance of the 
nigrostriatal DA system). Higher doses of these drugs produce stereotyped activity that 
consists of repetitive, invariant motor responses without purpose or goal (Kelley 2001). 
Locomotor activity and stereotypy are associated with the activation of mesolimbic and 
nigrostriatal dopaminergic pathways, respectively (Amalric and Koob 1993; Castall et al. 
1977; Costall et al. 1977; Creese and Iversen 1975; Kelly et al. 1975), suggesting a 
primary dopaminergic activating effect of psychostimulants. Specifically, the intra-
accumbens infusion of either cocaine or AMPH produces a locomotor stimulant effect 
(Delfs et al. 1990; Kelley et al. 1989), and the behavioral activation induced by 
psychostimulants is inhibited by intra-accumbens administration of DA antagonists or by 
destruction of mesolimbic DA neurons by 6-OHDA lesion (Joyce and Koob 1981; Kelly 
and Iversen 1976; Vaccarino et al. 1986). Overexpression of DA transporters in mutant 
mice enhances AMPH-induced hyperactivity (Salahpour et al. 2008). Both DA D1-like or 
D2-like receptor antagonists inhibit psychostimulant-induced behavioral activation (Delfs 
and Kelley 1990). The above evidence suggests that the psychomotor stimulant effect of 
cocaine and AMPH is mediated through increased DA neurotransmission in the 
mesolimbic and nigrostratial DA system (Swerdlow et al. 1986). However, caution 
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should be taken in that stimulant-induced locomotion or stereotype do not quantitively 
associated with DA response in either NAc or dorsal striatum (Kuczenski et al. 1991). 
Therefore, the appearance of specific behavior activation, especially the quantitive 
characteristic, is not solely dependent on the quantitative features of the caudate or 
accumbens DA response. Other neurochemical systems and mechanisms might be 
involved as well. 
Reinforcing effect of DA 
Of particular relevance to the subjective and addictive properties of 
psychostimulants are their reinforcing effects. Conditional place preference (CPP) is a 
test that is often used to evaluate preferences for environmental stimuli that have been 
associated with a positive or negative stimulus as a measure of reinforcing property. In 
the CPP test, animals will spend more time in the place where they have ever received 
cocaine or AMPH administration compared to the place paired with saline (Spyraki et al. 
1982a; b). Because drug use is a voluntary behavior of humans, a self-administration 
model is often used to measure self-regulated drug taking in animals. Cocaine and AMPH 
are both self-administered by rodents (Ettenberg et al. 1982; Lyness et al. 1979; Pettit et 
al. 1984; Roberts et al. 1977) and non-human primates (Johanson et al. 1976) as by 
humans. Furthermore, intracranial self-stimulation (ICSS) reward thresholds in rats are 
lowered immediately after low dose of cocaine self-administration, which indicates a 
facilitation of rewarding effects of the ICSS (Kenny et al. 2003). Collectively, this 
evidence suggests a reinforcing effect of cocaine and AMPH in animals as well.  
The ability of cocaine-like compounds to bind to the DA transporter closely 
correlates with their potency to induce conditioned place preference or to maintain self-
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administration (Ritz et al. 1990; Ritz et al. 1987). Pharmacological blockade of DA 
transmission by DA antagonists also attenuates cocaine self-administration in both 
rodents and non-human primates (Bergman et al. 1990; De Wit and Wise 1977; Wilson 
and Schuster 1972; Yokel and Wise 1976). The above evidence suggests that the 
reinforcing effect of psychostimulants is also mediated by DA. Moreover, destruction of 
dopaminergic nerve terminals in the NAc attenuates the reinforcing effects of cocaine and 
AMPH, shown by decreased self-administration behavior and CPP (Lyness et al. 1979; 
Pettit et al. 1984; Roberts et al. 1977; Roberts and Koob 1982; Roberts et al. 1980; 
Spyraki et al. 1982b), suggesting the mesolimbic DA system is the key circuit underlying 
the reinforcing effect of psychostimulants (Pierce and Kumaresan 2006). Furthermore, 
studies with D1-like and D2-like agonists or antagonists suggest that both D1-like and 
D2-like DA receptors are involved as well (Bachtell et al. 2005; Mello and Negus 1996; 
Platt et al. 2002). Another reason that the DA system has been the major target of 
research to understand the addictive property of psychostimulants is that the reinforcing 
effects of other addictive drugs (opiates, ethanol, cannabinoids and nicotine) are also 
partly due to increased DA transmission in limbic regions of the brain, even though they 
may have different primary sites and mechanisms of action (Pierce and Kumaresan 2006). 
Collectively, the mesolimbic DA system is critically involved in the reinforcing effect of 
psychostimulants and it is suggested that animals self-administer the drugs to maintain 
elevated extracellular DA levels (Ranaldi et al. 1999; Wise et al. 1995).  
To summarize, even though serotonin (Dukat et al. 2007; Muller et al. 2007; 
Neumaier et al. 2002; Parsons et al. 1996; 1999; Parsons et al. 1998; Shippenberg et al. 
2000) and norepinephrine systems (Drouin et al. 2002a; Drouin et al. 2002b; Ventura et al. 
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2003) modulate the behavioral and subjective effects of psychostimulants, current 
knowledge suggests that the ascending midbrain DA projections play a primary role in 
mediating both locomotor stimulant effects and reinforcing properties of 
psychostimulants (Kalivas and Nakamura 1999; Koob 1998; Pierce and Kumaresan 
2006). Recently, the role of NAc core vs. shell has also been investigated as they may 
serve different roles in the rewarding and locomotor stimulant effect of psychomotor 
stimulant drugs (Heimer et al. 1997; Sellings and Clarke 2003).  
 
1.5 DA and behavioral sensitization 
The psychomotor stimulant effect can increase with repeated administration of 
cocaine or AMPH such that lower doses of drug will produce an equivalent behavioral 
effect as that previously produced by higher doses of drug. This is called behavioral 
sensitization (Robinson and Berridge 1993). It is often produced by intermittent 
administration of psychomotor stimulants. In addition to experimenter-administered drug, 
drug self-administration can also induce behavioral sensitization (Hooks et al. 1994; 
Phillips and Di Ciano 1996). Behavioral sensitization persists from weeks to months after 
withdrawal from the drug. Heightened behavioral response produced by AMPH 
administration can even last for a year (Paulson et al. 1991; Robinson and Becker 1986b). 
Since behavioral sensitization persists for very long time, and more importantly, the same 
neural substrates mediate both locomotor stimulant and reinforcing effects of 
psychostimulants, the neural mechanisms mediating behavioral sensitization are 
hypothesized to contribute to addiction as well (Robinson and Berridge 1993; 2000a; 
2001).  
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Recent studies suggest that the VTA is a critical site for the initiation of 
psychomotor sensitization (Vanderschuren and Kalivas 2000; Vezina 2004). Direct 
injection of AMPH into the VTA has no acute locomotor stimulant effect, but repeated 
intra-VTA administration results in sensitized locomotor response to systemic injection of 
AMPH and cocaine. In contrast, intra-NAc AMPH injections do not lead to sensitization, 
but elicit a sensitized response in rats that received repeated AMPH injections (Cador et 
al. 1995; Hooks et al. 1992; Kalivas and Weber 1988; Paulson and Robinson 1991; 
Perugini and Vezina 1994; Stewart and Vezina 1989; Vezina 1996; Vezina and Stewart 
1990). Studies with D1 antagonists and agonists have established a critical role for D1 
DA receptors in induction of AMPH sensitization, but its role in cocaine sensitization is 
not conclusive (Vanderschuren and Kalivas 2000). Repeated administration of cocaine or 
AMPH induces subsensitivity of DA autoreceptors within the VTA or SNc (Ackerman 
and White 1990; Henry et al. 1989). This subsensitivity, however, does not persist and 
can be observed only for 1 to 4 days after discontinuation of cocaine injections 
(Ackerman and White 1990). The time course is consistent with the period when basal 
levels of extracellular DA and DA transporter binding are enhanced in NAc (Parsons et al. 
1991; Pilotte et al. 1994; Weiss et al. 1992). Considering the role of the VTA in the 
initiation of behavioral sensitization, the transient subsensitivity of VTA DA 
autoreceptors and the increases in basal DA transmission in the NAc may be important 
for triggering persistent alterations in DA terminal areas (Hammer 1995). 
Compared to the initiation of sensitization, neuroadaptations that occur among 
circuits innervated by DA neurons, especially the NAc and striatum, are more likely to 
mediate the expression of sensitization (Pierce and Kalivas 1997). As reviewed above, a 
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direct effect of cocaine and AMPH is to enhance extracelullar DA levels in NAc and 
striatum, which is thought to be responsible for their psychomotor stimulant and 
rewarding effects. Related to this idea, augmented overflow of DA in NAc and striatum 
induced by psychomotor stimulants among cocaine- or AMPH- pretreated rats has been 
reported (Heidbreder et al. 1996; Kalivas and Duffy 1990; 1993; Paulson and Robinson 
1995; Torregrossa and Kalivas 2007)}. This dopaminergic neuroadaptation, however, has 
been only consistently observed after a withdrawal of more than 14 days. Reduced, 
unaltered or enhanced ability of psychostimulants to enhance DA overflow have been 
reported at early withdrawal (Heidbreder et al. 1996; Hurd et al. 1989; Kalivas and Duffy 
1993; Paulson and Robinson 1995; Segal and Kuczenski 1992a; b; Weiss et al. 1992; 
Wolf et al. 1993). At the same time, the activity of the DA transporter is up-regulated 
during early withdrawal (Cass et al. 1993; Ng et al. 1991) and a reduction of transporter 
density in the NAc has been observed after a longer withdrawal (Pilotte et al. 1994; 
Sharpe et al. 1991; Wilson et al. 1994). The changes of DA transporter function may 
contribute to the above dynamic change of DA transmission.  
Besides those presynaptic changes, changes of postsynaptic function have been 
observed as well. In NAc, DA inhibits glutamate-evoked neural activity, and this effect is 
enhanced in psychostimulant-pretreated rats (Henry et al. 1989; Higashi et al. 1989; 
White et al. 1995), which may be related to the enhanced sensitivity of D1 receptors in 
NAc (Henry and White 1991). Interestingly, D1 receptor supersensitivity persists up to a 
month, which parallels the time course of increases in cocaine-induced inhibition of NAc 
neurons as well as behavioral sensitization induced by the same treatment regimen 
(Hammer 1995). Further more, D1 receptor antagonists abolish the expression of 
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behavioral sensitization, suggesting D1 receptors play an important role in the expression 
of sensitized behavior (Pierce et al. 1996; Pierce and Kalivas 1997). Studies examining 
D2 receptor binding after sensitization in rodents have mixed results with enhanced, 
reduced or unaltered D2 receptors binding being reported (Dwoskin et al. 1988; Kleven et 
al. 1990; Peris et al. 1990). Dopamine D2 receptors, however, exist in two 
interconvertible affinity states: high vs. low affinity state. Rats that have been sensisitzed 
to AMPH or self-administered cocaine have increased dopamine D2-high receptors 
(Briand et al. 2008; Seeman et al. 2004). Consistently, sensitized rats are usually 
hypersensitive to the psychomotor effects of D2 agonists (De Vries et al. 2002; Edwards 
et al. 2007; Ujike et al. 1990). Thus, changes in D2-high receptors may also contribute to 
the expression of behavioral sensitization.   
Taken together, repeated treatments of psychostimulants are associated with 
neuroadaptations in ascending midbrain DA system (Figure 1.2). Transient subsensitivity 
of autoreceptors in cell body region may contribute to the enhanced basal activity of DA 
neurons and transient increases in basal DA transmission in DA terminal regions. These 
transient responses might be important for initiating more persistent changes in DA 
terminal areas, including both presynaptic and postsynaptic neuroadaptations, which 
contribute to the expression of behavioral sensitization. Since behavioral sensitization 
develops early while different neuroplasticity occurs at early vs late stage after 
withdrawal, different mechanisms might be responsible for behavior sensitization seen 




Figure 1.2 Schematic representation of the key neural mechanism associated with 
cocaine sensitizaiton 
1.6 DA and drug-taking 
As reviewed above, an extensive body of literature demonstrates that enhanced DA 
transmission in the NAc critically contributes to the reinforcing effects of cocaine. 
Consistent with this idea, DA levels in accumbens are enhanced during cocaine self-
administration in rats and monkey (Czoty et al. 2000; Hurd et al. 1989; Pettit and Justice 
1989). Interestingly, the lever pressing for cocaine is initiated when accumbal DA 
concentrations decrease to a threshold level during the cocaine self-administration session, 
suggesting that rats self-administer cocaine to maintain DA levels in NAc (Kiyatkin and 
Stein 1995; Ranaldi et al. 1999; Wise et al. 1995). Additional support comes from the 
evidence showing that DA receptor antagonists and agonists always modulate cocaine 
self-administration (Britton et al. 1991; Caine and Koob 1994; Hubner and Moreton 
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1991; Woolverton 1986).  
In addition, a role for DA in the reinstatement of cocaine-seeking behavior has also 
been demonstrated. Most factors that trigger drug craving and induce reinstatement, such 
as drug priming, stress or drug associated cues, increase DA neuron firing or DA release 
(Nicola et al. 2005; Schultz 1998; Shaham et al. 2003). DA reuptake inhibitors or D2-like 
DA receptor agonists reinstate cocaine seeking whereas D2-like DA receptor antagonists 
attenuate cocaine priming-induced drug-seeking behavior (De Vries et al. 2002; De Vries 
et al. 1999; Khroyan et al. 2000; Schenk and Partridge 1999; Self et al. 1996; Spealman 
et al. 1999; Wise et al. 1990), suggesting that a role for DA in reinstatement of cocaine-
seeking is mediated by D2-like DA receptors. Moreover, reinstatement of cocaine self-
administration is promoted by direct stimulation of DA cell bodies in the VTA or 
application of DA in the NAc (Cornish and Kalivas 2000; Stewart 1984), suggesting a 
critical role for mesolimbic pathway in mediating cocaine-seeking behavior.  
Recently, more attention has been given to the role of the dorsal striatum in cocaine 
seeking behavior because psychostimulant administration produces significant changes in 
gene expression in the dorsal striatum (Curran et al. 1996; Graybiel et al. 1990). 
Extracellular DA is increased in the dorsal striatum rather than the NAc during 
responding for cocaine-associated cue after chronic cocaine self-administration (Ito et al. 
2000; Ito et al. 2002). Moreover, inactivation of the dorsal striatum attenuates cocaine 
seeking after forced abstinence whereas inactivation of NAc failed to do so (Fuchs et al. 
2006; See et al. 2007). Consistent with this idea, infusion of a DA receptor antagonist into 
the dorsal striatum decreases cocaine seeking under a second-order schedule of 
reinforcement (Vanderschuren et al. 2005). Recent development of neuroimaging 
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techniques provides additional clinical evidence. In cocaine-dependent subjects, DA 
release in response to cocaine-associated cues has also only been observed in the dorsal 
striatum and this increase has been positively associated with cocaine craving (Volkow et 
al. 2006; Wong et al. 2006). All of the above evidence points to a critical role of dorsal 
striatum DA in relapse. 
1.7 Sensitization and addiction 
In addition to behavioral sensitization, repeated exposure to psychostimulants results 
in an enhancement of the reinforcing effect of psychostimulants. For example, prior 
repeated drug treatment shifts the dose-effect curve for CPP to the left (Shippenberg and 
Heidbreder 1995; Shippenberg et al. 1996), shortens the latency or decreases the dose 
necessary for rats to acquire self-administration (Horger et al. 1992; Horger et al. 1990; 
Piazza et al. 1989; 1990). Moreover, sensitized rats reach higher “breaking point” in 
progressive ratio schedules, indicating a stronger motivation to obtain drug (Lorrain et al. 
2000; Mendrek et al. 1998).  
A relationship between sensitization and drug seeking has also been suggested based 
on the evidence that all of the drugs that elicit sensitized locomotor responses in drug 
pretreated rats cause reinstatement of previously extinguished drug seeking behavior 
(Vanderschuren et al. 1999b). Behavioral sensitization is very sensitive to the 
environment surrounding drug administration (Robinson et al. 1998). It is more readily to 
be induced when the drug is administered in a novel environement compared to home 
cages (Badiani et al. 1995). When a drug is repeatedly administered to rats in one 
environment, robust sensitized response is produced when the drug is subsequently 
administered in the same drug-paired environment. But sensitization may not be 
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expressed if the drug is administered in a non-paired environment (Anagnostaras and 
Robinson 1996; Mattson et al. 2008). Coincidently, reinstatement of drug self-
administration is reliably induced by drug-paired cues, including discrete cues, 
discriminative cues and contextual cues, after extinction of operant responding (Caprioli 
et al. 2007). Therefore, sensitization not only enhances the reinforcing effect of a drug 
itself, but also functionally recruits context and drug associated cues in drug abuse to 
powerfully modulate drug-taking behavior. It may account for the critical role of context 
in precipitating relapse in humans (Robinson and Berridge 1993; 2000a; 2003). 
The incentive-sensitization theory of addiction refers to an enhanced incentive 
salience-“wanting” of a drug after repeated drug exposure as incentive sensitization. In 
addition to drug, context may have also acquired some incentive salience in this process. 
Both context and drug result in excessive incentive motivation for drugs and lead to a 
shift from drug “liking” to “wanting” underlying compulsive drug use (Robinson and 
Berridge 1993; 2000a). Another popular view suggests that sensitization is a process to 
facilitate some forms of learning between drug and context, which results in habitual and 
compulsive drug use in addiction (Everitt et al. 1999; Everitt and Robbins 2005). 
Dysfunction of the frontocortical system, associated with the sensitization process, may 
occur and impair normal cognition and inhibitory control over behavior and contribute to 
irrationally compulsive drug pursuit (Jentsch and Taylor 1999). No matter what 
psychological function has been changed, persistent drug-induced neuroadaptations 
accompanying the sensitization processes are thought to be critical in the transition to 
addiction (Robinson and Berridge 2003).  
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1.8 DA and rewarding effects of psychomotor stimulants -insight from clinical 
imaging studies 
The majority of existing knowledge about the neural mechanisms mediating effects 
of psychostimulants has been built on preclinical studies; very little is known about 
humans. The recent development of neuroimaging techniques allows us to look at the 
effect of psychostimulants in the human brain directly and adds to our knowledge gained 
from animals. PET scan combined with DA type 2 and 3 receptor radiolabeled antagonist 
[11C] raclopride can be used to measure changes in extracellular DA in the human brain 
(Laruelle 2000). In humans, acute administration of AMPH significantly induced DA 
release in the limbic (ventral striatum) and sensorimotor (postcommissural putamen) 
region of striatum. Furthermore, the greater DA release in ventral striatum was associated 
with the increase of subjects’ reported euphoria (Drevets et al. 2001; Martinez et al. 2003). 
AMPH sensitization and the associated increased DA release in the ventral striatum 
has been modeled and observed in healthy human subjects in a laboratory study (Boileau 
et al. 2006). The subjects were administered oral AMPH (0.3 mg/kg) three times. When 
AMPH was given again 14 and 365 days after the last dose of AMPH, there was a greater 
psychomotor response and increased DA release relative to the initial dose in the ventral 
striatum. Moreover, cues associated with AMPH also increased DA release to the same 
magnitude as did AMPH in the ventral striatum (Boileau et al. 2007), supporting the idea 
that sensitization is associated with enhanced DA transmission, and this neuroadaptation 
is also modulated by the environment.  
Intriguingly, a reduction of methylphenidate- or AMPH- induced DA release in 
striatum has been reported in cocaine-dependent humans, which suggests an alteration in 
 19
presynaptic DA function in those dependent on cocaine (Martinez et al. 2007; Volkow et 
al. 1997). Participants with greater reduction in DA release in the anterior caudate and 
ventral striatum were more likely to choose cocaine over an alternative reinforcer in the 
self-administration session (Martinez et al. 2004). The absence of DA sensitization with 
extensive exposure to psychostimulants indicated by indirect measures of D2 ligand 
displacement in clinical imaging studies are supported by studies directly measuring DA 
release in monkeys (Bradberry and Rubino 2006), suggesting different mechanism may 
exist between non-human primates and humans as well as rodents. In terms of 
postsynaptic changes, decreased D2 receptor avaiablity in the striatum has been observed 
in cocaine addicts (Martinez et al. 2004; Volkow et al. 2004; Volkow et al. 1990). But 
until now, human imaging studies cannot differentiate D2 low vs. high affinity state, thus 
it is not clear if D2-high receptors has been upregulated in cocaine addicts.  
Collectively, the above clinical imaging studies confirm that an acute effect of 
psychomotor stiumulants is to enhance extracellular DA levels in the mesolimbic DA 
system, and the changes of DA level is associated with changes of subjective effect 
induced by the drug. The relationship of the neuroadaptations associated with repeated 
use of drugs and addiction in humans still remains open for further investigation. 
     
2. Sex differences in cocaine and AMPH abuse 
In the above section, I have reviewed the current understanding of the major neural 
mechanism mediating the psychomotor activating and reinforcing effect of psychomotor 
stimulants, and the neuroadaptations associated with repeated drug exposure, as well as 
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possible role of those circuits in drug abuse and addiction. Another characteristic we must 
pay attention to is individual differences in susceptibility to drug abuse and addiction. 
Recent studies suggest gender is an important factor influencing cocaine abuse (Becker 
and Hu 2008).  
Cocaine abuse had been traditionally considered a male issue because 
epidemiological data shows greater prevalence of drug use and dependence among males 
before. In recent years, many male-female differences, however, have gradually 
disappeared or even reversed especially when opportunity to use is considered and when 
drug dependence rates are calculated only among users (Van Etten et al. 1999). Recent 
epidemiological data reveal that women are three to four times more likely than men to 
become addicted to cocaine within 24 months from the first time of cocaine use (O'Brien 
and Anthony 2005). Furthermore, there is a significantly a shorter time from initiation of 
cocaine use to abuse and dependence (Ridenour et al. 2005), greater cocaine use, and 
more dependence on cocaine in women than men (Lejuez et al., 2007). This topic has 
drawn attention nation wide (Wetherington 2007). 
 
 
2.1 Gender difference in response to cocaine and AMPH -clinical evidence 
Cocaine 
Clinical studies suggest gender differences in response to cocaine because cocaine 
cues induce more drug craving in female than male addicts (Robbins et al. 1999). Women 
report less pleasure and greater anxiety after acute intranasal cocaine administration 
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(Kosten et al. 1996; Lukas et al. 1996). Repeated administrations of intranasal or 
intravenous cocaine produce a greater increase in “Feel Good” and greater cardiovascular 
effects in cocaine-dependent women (Haney et al. 1998; McCance-Katz et al. 2005).  
The effect of cocaine changes over the menstrual cycle.The human menstrual cycle 
(Figure 1.3) can be separated into two typical phases, which are follicular and luteal 
phases. In the follicular phase (day 1-14), estradiol levels are low at first, gradually rise 
and reach peak later, while progesterone levels are always low. The luteal phase (day 15-
28) is characterized by moderate estradiol and high progesterone levels (Becker and 
Breedlove 2002).  
Female subjects report more positive subjective effects of smoked or intravenous 
cocaine administration during the follicular phase than during the luteal phase (Evans and 
Foltin 2006; Evans et al. 2002; Mendelson et al. 1999b; Sofuoglu et al. 1999). The 
cardiovascular effects of smoked cocaine also change over the menstrual cycle (Evans 
and Foltin 2006; Evans et al. 2002). There were no menstrual cycle phase or sex 
differences, however, in cocaine plasma levels after intravenous or smoked cocaine 
(Evans and Foltin 2006; Evans et al. 2002; Mendelson et al. 1999b; Sofuoglu et al. 1999). 
Therefore, the differences of subjective and cardiovascular effects could not be accounted 




Figure 1.3 Schematic representation of changing hormonal profiles across the cycle 




The above evidence suggests that female gonadal hormones may modulate the 
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response to cocaine. It is possible that positive drug effects of cocaine are either enhanced 
by the presence of estradiol during the follicular phase, or decreased by the presence of 
progesterone in the luteal phase, or modulated by both processes. Clinical studies using 
exogenous estradiol or progesterone have found that administration of progesterone 
during the follicular phase in women attenuates the positive subjective effects of smoked 
cocaine and cocaine-induced diastolic blood pressure (Evans and Foltin 2006; Sofuoglu 
et al. 2002; Sofuoglu et al. 2004). The effect of progesterone in men is not conclusive, as 
the same inhibitory effect was evident in one study (Sofuoglu et al. 2004), but was not 
observed in another (Evans and Foltin 2006). In clinical studies, there has been very 
limited evidence suggesting that estradiol modulates the subjective response to cocaine 
(Evans 2007; Evans and Foltin 2006). 
AMPH 
Gender differences and the effect of menstrual cycle have also been reported in the 
effect of AMPH (Evans 2007; Terner and de Wit 2006). A study using a drug choice 
procedure found that women are more likely to choose 10 mg oral AMPH over placebo 
than do men (Gabbay 2003). In contrast, one recent neuroimaging study reported that 
men have greater DA release and greater positive subjective responses to an intravenous 
dose of AMPH (0.3 mg/kg) compared to women (Munro et al. 2006). A retrospective 
study, which has analyzed data from 6 studies from their lab, suggests men experience 
greater “high” and “sluggish” and less “nausea” than women (Vansickel et al. 2007). 
Unfortunately, this analysis also failed to take into consideration the phase of menstrual 
cycle in women. 
Studies examining the effect of menstrual cycle show that females feel more “high” 
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and “euphoria” after AMPH when they are in the follicular phase compared to the luteal 
phase. Greater AMPH-induced subjective effect during the follicular phase positively 
correlates with estradiol levels and negatively correlates with progesterone levels (Justice 
and de Wit 1999; White et al. 2002). In White’s study, the effect of AMPH has also been 
compared between genders. Men reported greater stimulation than women who are in the 
luteal phase (White et al. 2002). When the women were in the follicular phase, ratings of 
stimulation after oral AMPH were not different between men and women (Gabbay 2005). 
The above evidence suggests that estradiol and progesterone may modulate the subjective 
response of AMPH as it does on cocaine.  
A subsequent study assessing the subjective effect of AMPH during the early (low 
estradiol level) and late follicular (high estradiol level) phases of menstrual cycle found 
that women reported greater unpleasant stimulation and less unpleasant sedation during 
the late follicular phase than during the early follicular phase (Justice and De Wit 2000a). 
In another study, exogenous administration of estradiol was found to increase the 
magnitude of the effects of AMPH on subjective ratings of “pleasant stimulation’ and 
decrease ratings of ‘want more’ (Justice and de Wit 2000b). Taken togethet, it suggests 
the subjective effect of AMPH is modulated by estradiol. Until now, the effect of 
progesterone on the response to AMPH has not been examined. 
In summary, the current research suggests that there are gender differences in 
subjective response to both cocaine and AMPH. Since the subjective response to cocaine 
and AMPH in women fluctuates over menstrual cycle, the reported gender differences 
depend on when women are tested. However, one consistent finding is women tend to 
have greater euphoria experience to both cocaine and AMPH during follicular phase with 
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high estradiol and low progesterone level, than during luteal phase characterized by 
moderate estradiol and high progesterone. Furthermore, exogenous estradiol enhances 
some subjective effects of AMPH. In contrast, progesterone attenuates subjective effect 
of cocaine in women. More experiments are needed to further verify their specific role on 
psychostimulants-related response. Lastly, caution should be taken when interpreting 
results from clinical studies since most studies examining the effect of AMPH have been 
conducted on healthy people whereas cocaine’s effect have been examined in cocaine 
addicts. 
2.2 Sex differences in the effects of psychomotor stimulants- preclinical studies 
There has been an increase in preclinical research addressing sex differences in 
drugs of abuse, particularly on psychostimulants like AMPH and cocaine. This topic has 
been summarized recently in several reviews (Becker et al. 2001; Carroll et al. 2004; 
Festa and Quinones-Jenab 2004; Lynch et al. 2002; Mendelson et al. 2002; Roth et al. 
2004). Clinical studies gave us some clue in terms of variables to consider when we 
examine sex difference in response to psychomotor stimulants. Animal models allow us 
to manipulate and control all those variables and test the specific role of each. Current 
body of knowledge gained from preclinical studies will be summarized below.  
Sex differences in the effects of psychostimulants were first reported in the AMPH-
stimulated behavioral response in rats (Beatty and Holzer 1978; Meyer and Lytle 1978). 
Female rats show greater and prolonged locomotor behavior, stereotypy and rotational 
behavior in response to acute AMPH than do male rats (Beatty and Holzer 1978; Becker 
et al. 1982; Bisagno et al. 2003; Camp et al. 1986; Milesi-Halle et al. 2007). Similar 
observations in the effect of cocaine have also been reported in rodents, including 
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cocaine-induced locomotor activity, conditioned rewarding effect as well as cocaine self-
administration (Becker and Hu 2008; Becker et al. 2001; Bowman and Kuhn 1996; Caine 
et al. 2004; Dalton et al. 1986; Glick et al. 1983; Hu et al. 2004; Lynch and Taylor 2005; 
Russo et al. 2003b; Thompson et al. 1984; van Haaren and Meyer 1991; Walker et al. 
2001). Females show substantially greater cocaine-induced locomotor behavior than 
males (Glick et al. 1983; Hu et al. 2004; van Haaren and Meyer 1991), require less 
pairing sessions to develop cocaine CPP (Russo et al. 2003b), acquire self-administration 
more rapidly and self-administered more cocaine (Lynch and Carroll 1999), and are more 
sensitive to cocaine priming during the reinstatement of cocaine seeking (Lynch and 
Carroll 2000).  
Besides acute effect of psychomotor stimulants, sex differences have also been 
reported after repeated administration of psychostimulants. Female rats exhibit greater 
behavioral sensitization in response to AMPH and cocaine than do male rats (Camp and 
Robinson 1988a; b; Chin et al. 2002; Chin et al. 2001; Forgie and Stewart 1994; 
Robinson 1984; Robinson et al. 1982; van Haaren and Meyer 1991). Besides those 
quantitative differences of behavioral response, males and females also exhibit qualitative 
differences in drug-taking behavior. Using drug self-administration model, females 
exhibit greater reinstatement in the drug-primed reinstatement procedure (Lynch and 
Carroll 2000). In contrast, males exhibit greater reinstatement in the cue-induced 
reinstatement procedure (Fuchs et al. 2005). It suggests that the factors precipitating 
relapse might be different for males and females. 
Several factors may contribute to the sex differences in response to cocaine and 
AMPH. First of all, due to both genetic differences and organizational effects of 
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hormones, fetuses go through sexual differentiation during development to form sexually 
dimorphic brain. This intrinsic sex differences independent of circulating gonadal 
hormones in adulthood may directly lead to sex differences in response to 
psychostimulants. Secondly, males and females have different gonadal hormones as 
adults. Estradiol and progesterone are produced by ovaries in females, and testosterone is 
produced by testes in males. The activational effect of these hormones may make males 
and females show sexually dimorphic behavioral response to psychostimulants. Thirdly, 
the above two processes may interact and work together to contribute to sex differences 
in response to psychostimulants (Figure 1.4). The three hypotheses are discussed below. 
 
 






2.2.1 Sex differences independent of gonadal hormones 
Castrated male rats (CAST) and ovariectomized (OVX) female rats are often used to 
test whether there is a sex difference in brain that is independent of gonadal hormones. It 
has been shown that OVX female rats exhibit greater behavioral sensitization to cocaine,  
acquire cocaine self-administration behavior more rapidly, and self-administer more 
cocaine at a faster rate than CAST male rats (Becker et al. 2001; Hu and Becker 2003; Hu 
et al. 2004). These data suggest that there is sex difference in the effect of cocaine and 
AMPH even without circulating gonadal hormones. 
2.2.2 Effect of Testosterone  
Experiments comparing CAST males and intact males found that castration has no 
effect on locomotor activity induced by acute cocaine (van Haaren and Meyer 1991) or 
rotational behavioral induced by acute AMPH or electrical stimulation (Camp et al. 1986; 
Robinson et al. 1981), or on cocaine self-administration (Hu et al. 2004). Collectively, it 
suggests testosterone does not modulate the acute response to psychostimulants.  
In addition to the acute response, castration has no effect on sensitization of 
locomotor activity, stereotyped activity and rotational behavioral after repeated injections 
of cocaine (Becker et al. 2001; Hu and Becker 2003; van Haaren and Meyer 1991). 
Intriguingly, the effect of testosterone on behavioral sensitization to AMPH is not 
conclusive. Some studies have shown that CAST male rats exhibit greater sensitization to 
AMPH than do intact male rats (Camp and Robinson 1988a; b; Robinson 1984). But 
others have reported neither an effect of castration at enhancing behavioral sensitization 
nor a suppressing effect of exogenous testosterone on CAST male rats (Forgie and 
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Stewart 1994).  
2.2.3 Effect of Estradiol 
Female rats have a 4-5 day estrous cycle with four stages (Figure 1.3), that are 
referred to as diestrus (diestrus II), metestrus, proestrus and estrus (diestrus I). Estradiol is 
low during diestrus and metestrus. It rises gradually until approximately noon on 
proestrus, when there is a surge of estradiol that triggers ovulation 12 hours later (Becker 
and Breedlove 2002).  
There is estrous cycle-dependent variation in behavior induced by AMPH or cocaine 
with greater behavior exhibited in estrus (Becker and Cha 1989; Becker et al. 1982). 
Females’ self-administration behavior fluctuates over estrous cycle as well with higher 
motivation to take cocaine during estrus (Lynch et al. 2000; Roberts et al. 1989). 
Following high-dose cocaine priming, females in estrus exhibit higher reinstatement than 
either males or non-estrus females (Kippin et al. 2005).  
The effect of estradiol on the behavioral response to cocaine after first 
administration is not conclusive depending on the specific estradiol treatment. An acute 
effect of estradiol on locomotor activity after a first injection of cocaine has not been 
observed in the studies when estradiol was administered just prior to cocaine injections 
(Hu and Becker 2003; Peris et al. 1991; Perrotti et al. 2000; Sircar and Kim 1999; Yang et 
al. 2007). A role for estradiol, however, has been reported in several other studies when 
estradiol benzoate-filled silastic capsules were implanted some time before the testing  
(Perrotti et al. 2001; Quinones-Jenab et al. 2000; Sell et al. 2000). The differential effect 
may be due to short vs. long exposure to estradiol. Unlike cocaine, the behavioral 
responses to AMPH are enhanced rapidly by estradiol (Becker 1990b; Becker and Beer 
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1986). As reviewed previously, AMPH both releases DA and blocks DA reuptakes, which 
makes AMPH more efficacious than cocaine. The greater efficacy may make AMPH-
induced behavioral activation more sensitive to the regulation of estradiol (Hu and 
Becker 2003).  
In terms of the behavioral response to repeated drug administrations, OVX females 
sometimes do not show behavioral sensitization to cocaine at time when intact females or 
gonadal hormone-treated females do (Peris et al. 1991; Sircar and Kim 1999; van Haaren 
and Meyer 1991). Hormone replacement experiments demonstrate that estradiol enhances 
behavioral sensitization to cocaine in female rats in a variety of behavioral paradigms, 
such as locomotor behavior, stereotypy, rotational behavior (Becker et al. 2001; Chin et al. 
2002; Hu and Becker 2003; Peris et al. 1991; Perrotti et al. 2001; Sell et al. 2002; Sircar 
and Kim 1999; Yang et al. 2007; Zhen et al. 2007). Interestingly, most studies find that 
ovariectomy in female rats does not affect AMPH sensitization (Camp and Robinson 
1988a; b; Forgie and Stewart 1994; Robinson 1984; Robinson et al. 1982).  
In addition to the psychomotor stimulant effect, estradiol also powerfully modulates 
cocaine-taking behavior. In female rats estradiol enhances the acquisition of cocaine self-
administration (Hu et al. 2004; Jackson et al. 2006; Lynch et al. 2001), cocaine-induced 
reinstatement (Larson and Carroll 2007; Larson et al. 2005) and females’ motivation to 
take cocaine as exhibited by a higher breaking point on a progressive ratio schedule 
(Becker and Hu 2008). In an extended drug seeking model, estradiol also promotes 
escalation of cocaine self-administration when rats have access to cocaine for more than 
6 hours per day (Larson et al. 2007). 
Collectively, the above results strongly suggest that estradiol facilitates the 
 31
behavioral response to psychomotor stimulants. Moreover, the effect of estradiol is 
sexually dimorphic as it has no effect on cocaine sensitization or cocaine self-
administration on CAST male rats (Becker et al. 2001; Jackson et al. 2006) 
2.2.4 Effect of Progesterone 
Progesterone is suggested as an agent that may attenuate the cocaine response in 
women in clinical studies (Evans and Foltin 2006; Sofuoglu et al. 2002; Sofuoglu et al. 
2004). Consistent with this idea, a recent preclinical study monitoring plasma 
progesterone and estradiol level as well as cocaine seeking behavior in cycling female 
rats have found that the highest progesterone levels occur at the time of lowest cocaine-
seeking and lowest levels occur at the time of highest cocaine-seeking (Feltenstein and 
See 2007). The inhibitory effect of progesterone is also suggested by the studies showing 
that progesterone treatment blocks the conditioned place preference for cocaine in mice 
(Romieu et al. 2003) and rats (Russo et al. 2003a; Russo et al. 2008), suppresses cocaine-
induced reinstatement of cocaine-seeking (Anker et al. 2007), and inhibits the escalation 
of cocaine self-administration in an extended drug seeking model (Larson et al. 2007). In 
contrast to the reinforcement effect, cocaine-induced psychomotor activation seems to be 
invulnerable to the regulation of progesterone, as progesterone has no effect on cocaine-
induced locomotive acitivity (Perrotti et al. 2001; Sell et al. 2000; Sircar and Kim 1999). 
The effect of progesterone is dose dependent because low and high doses inhibit, whereas 
intermediate doses stimulate, rearing responses (Niyomchai et al. 2005). One caution to 
be kept in mind is that the above experiments have also employed different 
administration routes, such as progesterone replacement via silastic capsules vs. 
subcutaneous injections. Thus, the effect of progesterone is dose and route dependent. 
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Different mechanisms might be involved and have yet to be determined. 
    In addition to an independent role of progesterone, an interaction between 
progesterone and estradiol has been suggested as well. For example, administration of 
estradiol and progesterone suppressed cocaine-induced locomotion and cocaine self-
administration when compared to estradiol-treated animals (Jackson et al. 2006; 
Quinones-Jenab et al. 2000). An acute administration of progesterone, however, enhances 
cocaine-induced locomotor activity in estradiol-primed OVX rats (Perrotti et al. 2001). 
Moreover, OVX rats implanted with silastic capsules containing both estradiol and 
progesterone exhibit greater magnitude of cocaine conditioned place preference (Russo et 
al. 2003a). Due to this conflicting evidence, the effect of progesterone still remains to be 
determined. It is possible that progesterone plays a role in the facilitation or inhibition of 
estradiol’s effect on cocaine-induced behavior depending on when it is administered.  
To summarize this part, preclinical studies suggest that males and females have 
intrinsically different brains that make females more vulnerable to the effect of 
psychomotor stimulants than males. In addition, preclinical studies strongly suggest an 
important role of estradiol on the response to cocaine and AMPH. The facilitative effect 
of estradiol is evident on females rather than males suggesting that it works on sexually 
dimorphic brain. Progesterone can either facilitate or antagonize the effect of estradiol 
depending on when it is administered. Furthermore, most evidence supports the notion 






3. Neural mechanisms mediating sex differences on psychotimulant- 
related effects 
3.1 Sex differences in pharmacokinetics of psychomotor stimulants 
Sex differences exits in the metabolism of AMPH. AMPH is metabolized more 
rapidly in males than in female rats so that brain levels are lower in males than in females 
if they receive the same systemic dose of AMPH (Kato 1974; Meyer and Lytle 1978). It 
may explain some discrepancy among studies. However, studies administering different 
dose of AMPH to achieve equivalent brain concentration of AMPH still found an greater 
behavioral response to AMPH in females (Becker et al. 1982; Bisagno et al. 2003; Camp 
et al. 1986). 
There are fewer problems with studies investigating sex differences in the effects of 
cocaine, since there is neither a sex difference nor an effect of gonadal hormones on 
plasma or brain cocaine levels after acute cocaine injection in rodents (Bowman et al. 
1999). Similar results have been obtained in humans and rhesus monkeys as well 
(Mendelson et al. 1999a; Mendelson et al. 1999b). A recent study found lower brain 
levels of cocaine 30 minutes after cocaine administration in estradiol-treated rats, but 
those changes play very limited role in mediating behavior responses to cocaine 
especially considering that estradiol-treated rats exhibit a greater behavioral response to 
cocaine (Niyomchai et al. 2006).  
Therefore, sex differences in response to psychomotor stimulants cannot be 
explained by differences in pharmacokinetics of cocaine or AMPH, even though sex 
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differences in AMPH metabolism exist and may partly contribute to some of the reported 
differences. 
3.2 Sex differences in the brain 
Recent clinical imaging studies have demonstrated that cocaine-dependent men and 
women exhibit different brain responses. For example, regional cerebral blood flow 
(rCBF) and perfusion abnormalities on cocaine-dependent men and women have been 
found to exhibit gender-specific patterns (Adinoff et al. 2006; Tucker et al. 2004). Gender 
differences in the functional anatomy of cue-induced cocaine craving have been reported 
as well (Kilts et al. 2004). Conditioned cocaine craving in women is associated with less 
activation of amygdala, insula, orbitofrontal cortex, and ventral cingulated cortex and 
greater activation of the central sulcus and frontal cortical area as compared to men (Kilts 
et al. 2004). Moreover, anticipation of uncertain reward activates ventral putamen more 
in man than women (Dreher et al. 2007). All of the above evidence suggests that different 
neural mechanisms may exist in cocaine-dependent men and women.  
Further preclinical studies have shown that the striatum and NAc are sexually 
dimorphic. For example, male rats have more D1 DA receptors (Hruska et al. 1982; 
Levesque and Di Paolo 1988). Female rats, however, exhibit greater sensitivity to the 
effect of D1 receptor antagonist at attenuating cocaine-induced psychomotor activation. 
Moreover, the striatal D1 binding level is reduced by acute cocaine administration only in 
male rats (Festa et al. 2006). Thus, D1 receptor may be an important substrate in 
regulating sex differences in cocaine-induced psychomotor activation.  
The basal DA as well as AMPH-stimulated striatal DA release are higher in CAST 
male rats than in OVX female rats (Becker and Ramirez 1981b; Xiao and Becker 1994). 
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In addition, male rats have a lower density of DA transporter mRNA in striatum than do 
intact or OVX female rats (Bosse et al. 1997). This suggests that there is an intrinsic sex 
difference in the organization of the striatum. Furthermore, there is a significantly greater 
percentage of AMPH-stimulated immediately early gene expression in the middle and 
caudal dorsal striatum in proestrous female rats than in female rats in any other stage, 
CAST male or intact male rats (Castner and Becker 1996), suggesting that gonadal 
hormones, in addition to an intrinsic sex difference, may also work on the ascending 
midbrain DA system to contribute to the sex differences in response to psychostimulants. 
Related to sex differences in long term effect of cocaine, a very recent study 
comparing the PKA-regulated signaling in striatum and NAc, which may be critical in the 
development of addiction, have reported that females had higher phosphorylated DA and 
cAMP-regulated phosphoprotein of 32 kDa (DARPP-32) at the PKA site in the striatum 
compared to males. Moreover, increased phorphorylation of DARPP-32 as a result of 
cocaine self-administration was observed in NAc after 10-days abstinence period in 
females and after 0-days abstenance period in males, suggesting gender-specific patterns 
may exist in the development of cocaine addiction (Lynch et al. 2007).     
Unfortunately, since gonadal hormone levels have not been monitored or controlled 
well in clinical and preclinical studies, and furthermore, cocaine use directly disrupts 
reproductive endocrine functions (King et al. 1993; King et al. 1990; Siegel 1982), it is 
hard to determine if the observations are due to pure intrinsic brain difference, an effect 




3.3 Ovarian hormones and ascending midbrain DA system 
As predicted by behavioral studies, gonadal hormones, in particular estradiol and 
progesterone, have a tremendous effect on the nigrostriatal and mesolimbic dopaminergic 
system (Becker 1999). The first line of evidence comes from the studies showing natural 
fluctuations of DA neural activity throughout the estrous cycle. Basal extracellular DA 
concentration in the striatum is higher when the rats are in estrus and proestrus with high 
endogenous estradiol (Xiao and Becker 1994). Besides basal DA, AMPH-induced 
increases in extracellular DA in striatum show estrous cycle-dependent variation with 
significantly greater AMPH-induced increase during estrus both in vivo and in vitro 
(Becker and Cha 1989; Becker and Ramirez 1981b). Moreover, the striatal DA uptake 
site density and DA receptors vary across estrous cycle (Di Paolo et al. 1988; Levesque et 
al. 1989; Morissette and Di Paolo 1993b). DA turnover and potassium-stimulated DA 
release and reuptake fluctuate over estrous cycle in the NAc as well (Shimizu and Bray 
1993; Thompson and Moss 1997). Interestingly, a very recent clinical study using fMRI 
found that reward-related neural functions in women were modulated by menstrual cycle. 
Reward delivery activates the midbrain striatum more in women in the follicular phase 
than during the luteal phase, which is consistent with menstrual cycle fluctuation of 
subjective effect of cocaine and AMPH (Dreher et al. 2007).  
The second line of evidence comes from gonadectomy studies. OVX decreases DA 
levels in VTA (Russo et al. 2003a), basal extracellular DA concentrations in striatum 
(Xiao and Becker 1994), AMPH-stimulated striatal DA release (Becker and Ramirez 
1981a; b), striatal DA transporter density (Bosse et al. 1997), striatal D1 DA receptor 
density (Levesque et al. 1989) and DA-stimulated adenylate cyclase activity in striatum 
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and NAc (Kumakura et al. 1979). The function of D2 DA receptors, however, is 
upregulated after OVX (Hruska et al. 1982).  
Taken together, these studies suggest that female gonadal hormones play a role in 
modulating the functions of DA system, which is probably the mechanism mediating 
hormone’s effect on psychostimulants-related effects. Extensive hormone replacement 
studies have been done to address specific role of estradiol and progesterone on DA 
system.  
3.3.1 Estradiol and DA 
Estradiol enters the cell to induce protein synthesis through its actions on nuclear 
receptors, which is termed genomic effect. Genomic effects are characterized by slow 
onset and prolonged duration. In addition, estradiol also has direct effects on the cell 
membrane, resulting in changes in electrical potential and the release of neurotransmitters. 
This nongenomic effect has a rapid onset and is short in duration (McEwen and Alves 
1999). Both pro- and antidopmainergic effects of estradiol have been reported depending 
on the dose and time course of estradiol treatment (Di Paolo 1994). Different effect of 
estradiol on dopaminergic function might be due to either genomic effects or nongenomic 
effects or a combination.  
Some evidence suggests a rapid effect of estradiol on the DA neurotransmission in 
the striatum of female rats. For example, acute estrogen treatment rapidly induces an 
increase in striatal DA turnover (Di Paolo et al. 1985), upregulates striatal DA uptake site 
density (Morissette et al. 1990), and decreases D2 class DA receptors (Bazzett and 
Becker 1994). Furthermore, direct application of estradiol to the striatal tissue from OVX 
rats enhances AMPH-induced DA release in vitro (Becker 1990a). Moreover, an acute 
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administration of estradiol to OVX rats induced a rapid increase in AMPH- or cocaine-
induced DA release in striatum in vivo (Becker 1990b; Becker and Rudick 1999; Hu and 
Becker 2006). The rapid effect of estrogen on striatal DA release is antagonized by the 
pure estrogen receptor antagonist rather than a nonsteroid agent with antiestrogenic 
property, suggesting that the steroidal feature is critical for the estrogen-binding site in 
the striatum (Xiao et al. 2003). Electrophysiological experiments using whole-cell clamp 
recording demonstrated that a low dose of 17β-estradiol inhibits the L-type calcium 
current within milliseconds through a G-protein-coupled process (Mermelstein et al. 
1996). Furthermore, bovine serum albumin conjugated-, membrane-impermeable 
estradiol mimics the effect of estradiol suggesting that estradiol works in the striatum 
through a non-genomic activation on extracellular cell membrane. Similarly, direct 
infusion of estradiol into the NAc also potentiated K+-stimulated DA release (Thompson 
and Moss 1994), and attenuated autoreceptor-mediated potentiation of DA uptake 
(Thompson 1999; Thompson et al. 2000). Moreover, estradiol rapidly enhanced cocaine-
stimulated DA increase in dialysate in NAc as in striatum (Hu and Becker 2006). A 
similar non-genomic effect of estrogen on membrane receptors in NAc is suggested as 
well (Wong et al. 1996).  
A model proposed by Becker hypothesizes that estradiol acts on estrogen receptors 
located on the membranes of medium spiny striatal neurons to reduce calcium current 
and result in a decreased GABA release, which then disinhibits DA neuron terminals to 
enhance stimulated striatal DA release (Becker 1999; Becker and Hu 2008). This 
hypothesis is further supported by the evidence showing that estradiol treatment rapidly 
attenuates potassium stimulated striatal GABA release in dialysate (Hu et al. 2006). The 
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above evidence may explain the effect of estradiol on response to acute treatment of 
psychostimulants.  
Related to the effect of estradiol on behavioral sensitization to cocaine, AMPH-
stimulated DA release from striatal tissue is greater in estradiol-treated OVX rats 
compared to OVX rats after cocaine sensitization (Peris et al. 1991). It is hard to judge, 
however, if this is due to an interaction of repeated cocaine treatment with long term or 
acute effects of estradiol or both. A microdialysis study shows that repeated treatments of 
estradiol produce greater enhancement of AMPH-induced DA release in dorsolateral 
striatum than a single acute treatment, suggesting estradiol treatment produces both acute 
and long-term effects in the striatum (Becker and Rudick 1999). Besides enhanced DA 
transmission, other long term effects of estradiol on DA system, probably through 
genomic activation, have been reported as well. For example, chronic estradiol treatment 
increases D2 receptor sensitivity and density in the striatum and NAc (Hruska and 
Silbergeld 1980; Lammers et al. 1999; Landry et al. 2002; Zhou et al. 2002), increases 
DA uptake site density in the nigrostriatal dopaminergic system (Morissette and Di Paolo 
1993a), increases turnover of DA in the nucleus accumben (Shimizu and Bray 1993), 
decreases the expression of DAT in striatal astroglia cultures and results in lower 
clearance of DA from the extracellular space (Karakaya et al. 2007). In cultured striatal 
neurons from embryonic mouse, chronic estradiol modified the G-protein coupling 
process to modulate adenylate cyclase activity stimulated by D1 and D2 DA receptor 
agonist (Maus et al. 1989a; Maus et al. 1989b). Whether or how those changes produced 
by long term effect of estradiol contribute to specific responses produced by either acute 
or repeated treatment of psychostimulants, however, still remains open. 
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For many years, the classical intracellular estrogen receptor (ERα), discovered in the 
early 1960s, was the only receptor known to mediate the effect of estrogen. Recently, a 
new β-isoform of estrogen receptor (ERβ) has been identified (Kuiper et al. 1996; 
Pettersson et al. 1997; Tremblay et al. 1997). None of these receptors, however, has been 
detected in the nucleus of neurons in adult rat striatum and NAc (Laflamme et al. 1998; 
Perez et al. 2003; Shughrue et al. 1997; Simerly et al. 1990; Zhang et al. 2002). But ERα 
and ERβ mRNA expression have been reported in developing and adult mice striatum 
(Kuppers and Beyer 1999) and in rat substantia nigra (Laflamme et al. 1998; Shughrue et 
al. 1997). ERβ mRNA and protein have also been found in the VTA (Creutz and Kritzer 
2002; Shughrue et al. 1997; Shughrue and Merchenthaler 2001). Investigators are just 
beginning to differentiate the role of ERα and ERβ in drug-related effects using newly 
developed ERα- and ERβ-selective agonists. The effect of chronic estradiol treatment to 
increase D2 receptor density in the striatum and NAc in OVX rats is reported to be 
through ERβ (Le Saux et al. 2006). Consistent with a critical role of accumbens D2 DA 
receptors in reinstatement of drug-seeking, ERβ is suggested to mediate estradiol’s effect 
at precipitating relapse (Larson and Carroll 2007). At the same time, ERα has been 
suggested to mediate estradiol’s effect at enhancing psychostimulant-induced locomotor 
activity (Larson and Carroll 2007). However, those results should be taken very carefully 
since ERβ-selective agonist DPN (70:1 ERβ: ERα) may stimulate ERα as well, especially 
after chronic treatment (Meyers et al. 2001).  
Even though both ERα and ERβ are traditional intracellular estradiol receptors, 
some evidence suggests both of them may be present in the cell membrane as well and 
mediate the rapid responses to estradiol (Milner et al. 2001; Norfleet et al. 1999; Watson 
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et al. 1999). Distinct from those traditional ERs, a G-protein coupled membrane estrogen 
receptor (mER) has been identified in the brain and mediates rapid response to estradiol 
in the hippocampus (Funakoshi et al. 2006; Qiu et al. 2006). A series of very recent 
studies further identified that, in hippocampal neurons, activation of membrane estrogen 
receptors, probably through caveolin protein, leads to metabotropic glutamate receptors 
activation and initiates cell signaling(Boulware et al. 2007; Dewing et al. 2007; Micevych 
and Mermelstein 2008). It is not known yet whether these receptors are found in the 
reward system. Nonetheless, compelling evidence showing the rapid effects of estradiol 
on striatal and accumbens DA neuron and drug-related effects, suggests the existence of 
membrane-located estrogen receptors in striatum and NAc.  
Taken together, estradiol has both acute and long term effects on the ascending DA 
system, through which it modulates response to psychostimulants. Failure to identify 
estrogen receptors in NAc and striatum, however, present a big challenge to further 
clarify the molecular and cellular mechanism involved.  
3.3.2 Progesterone and DA 
Until now, the effects of progesterone on dopaminergic function as well as 
psychostimulants-related effects have not been investigated extensively. A series of 
studies conducted in the Ramirez lab suggest that estradiol and progesterone collaborate 
to modulate DA neuron. Progesterone treatment either in vivo or in vitro enhances DA 
release in striatal tissue from extradiol-primed OVX female rats (Dluzen and Ramirez 
1984; 1987; 1989a; 1990b; 1991). A microdialysis study has confirmed the idea that 
progesterone treatment enhances AMPH-stimulated DA in dialysate from dorsolateral 
striatum in estradiol-pretreated OVX female rats (Becker and Rudick 1999). The effect of 
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progesterone on DA release from striatum is suggested to be mediated through a surface 
membrane site on interneurons in the striatum (Dluzen and Ramirez 1989a; b). A 
membrane-associated protein with high affinity for progesterone has been found in the 
striatum after estradiol priming (Ke and Ramirez 1990; Ramirez et al. 1996; Tischkau and 
Ramirez 1993). Estradiol plus progesterone also increases DA levels in the NAc (Russo 
et al. 2003a). Those effects of progesterone on striatal DA release are not seen without 
estradiol priming. Thus, some long-term effects of estradiol may be mediated through 
progesterone.  
Without estradiol priming, progesterone alone can influence dopaminergic function 
as well. Chronic progesterone treatment alone or in combination with estradiol increased 
DA reuptake sites in striatum and substantia nigra pars compacta to the same extend as 
estradiol treatment alone (Morissette and Di Paolo 1993a). It also decreases turnover of 
DA in the NAc (Shimizu and Bray 1993).  
    Taken together, even though progesterone can work alone to influence DA system, 
many effects of progesterone on DA system are through an interaction with estradiol.  
4. Specific aims 
My dissertation work has been trying to further clarify the underlying mechanisms 
mediating sex differences in response to cocaine. Based on current understanding of 
neural mechanisms mediating the effects of psychostimulants and sex differences in brain 
functions, I hypothesize that behavioral sensitization is a process that enhances both 
behavioral stimulant and reinforcing effect of psychostimulants, probably through 
enhanced ascending midbrain dopaminergic transmission, in females as in males. In 
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addition, there are sex differences in cocaine sensitization. Both intrinsic sex differences 
in the brain, that is independent of gonadal hormones, and estradiol contribute to sex 
differences in cocaine sensitization. In particular, estradiol may both produce an acute 
activational effect on sensitizated brain as well as influence neural process associated 
with sensitization to enhance behavioral sensitization in females. Moreover, the 
ascending midbrain DA system is sexually dimorphic and is powerfully modulated by 
estradiol, which is the neural substrate mediating the observed sex differences in 
behavioral sensitization.  
 
Aim 1(Chapter II): This experiment was designed to further characterize the effect of 
estradiol on behavioral sensitization in female rats by comparing the effect of estradiol 
given with repeated cocaine treatments vs. the effect of estradiol on a challenge day to 
determine: 1) if estradiol enhances behavioral sensitization when it is given with repeated 
cocaine treatments; 2) if enhanced sensitization produced by estradiol treatment during 
the time that sensitization is induced by cocaine treatment could be seen when on 
challenge day, whether or not estradiol is given on the challenge day; 3) if estradiol 
treatment on challenge day has additional acute effect on behavioral response to cocaine 
on cocaine-sensitized rats.  
Rationale: estradiol has been shown to enhance behavioral sensitization to cocaine in 
female rats (Chin et al. 2002; Hu and Becker 2003; Sircar and Kim 1999; Yang et al. 
2007), but most studies have used implanted estradiol-releasing pellets or have given 
subcutaneous estradiol injections throughout the whole process of sensitization (Becker et 
al. 2001; Febo et al. 2003; Peris et al. 1991; Perrotti et al. 2001). It is not clear whether 
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estradiol modulates the neural process occurring with the development of cocaine 
sensitization, or just produces an activational effect on naïve brain and sensitized brain, or 
do both to enhance cocaine sensitization (Figure 1.5) 
 
Figure 1.5 Possible mechanisms through which estradiol may work to modulate 
behavioral sensitizaiton 
 
This study was designed to look at the effect of estradiol on behavioral sensitization 
when administered during cocaine treatment vs. prior to cocaine injection on the 
challenge day to provide insight to the above question. I hypothesize that estradiol would 
facilitate the induction of behavioral sensitization to cocaine; this enhanced behavioral 
sensitization produced by estradiol treatment with repeated cocaine treatment would be 
induced by cocaine on challenge day, independently of the presence of estradiol. 
Estradiol treatment on the challenge day would produce acute enhancing effect on 
behavioral response to cocaine in cocaine-sensitized rats.  
 45
Aim 2 (Chapter III): To determine whether 1) cocaine sensitization promotes the 
acquisition of cocaine self-administration in female rats; 2) estradiol further promotes the 
acquisition of cocaine self-administration in cocaine-pretreated rats; 3) there is enhanced 
DA transmission in striatum and NAc accompanying behavioral changes.  
Rationale: there is evidence showing that preexposure to cocaine predisposes the rats to 
the rewarding effect of cocaine (Childs et al. 2006; Horger et al. 1990). Some studies 
have shown that prior exposure to psychostimulants enhances cocaine or AMPH self-
administration behavior in male rats (Ferrario and Robinson 2007; Piazza et al. 1989; 
1990; Suto et al. 2002; Vezina et al. 2002), and this behavioral change is probably 
mediated through sensitized DA neuron reactivity (Vezina 2004). This hypothesis has not 
yet been tested in females. This study was designed to investigate the effect of cocaine 
sensitization on acquisition of cocaine self-administration in females. In addition, 
estradiol is known to enhance the acquisition of cocaine self-administration in female rats 
(Hu et al. 2004; Lynch et al. 2001). The effect of estradiol on cocaine self-administration 
in cocaine-sensitized rats was also examined in this study. AMPH-induced striatal and 
accumbal DA release were compared between cocaine-experienced rats and cocaine-
naïve rats to test if enhanced DA transmission is involved. I hypothesize that prior 
sensitization would promote the acquisition of cocaine self-administration in female rats, 
and estradiol would further enhance drug taking behavior in sensitized female rats. 
Moreover, cocaine exposure would result in enhanced DA transmission in both striatum 
and NAc. 
Aim 3 (Chapter IV): To characterize the extracellular DA in dialysis in striatum of 
CAST males, OVX females and estradiol-treated OVX females after cocaine sensitization 
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to determine if: 1) there is a long term change in the nigrostriatal DA system due to 
repeated cocaine treatment; 2) this change will show a sexually dimorphic pattern or is 
modulated by estradiol. 
Rationale: OVX female rats show enhanced behavioral sensitization relative to CAST 
male rats, and estradiol treatment further enhances sensitization in OVX female rats (Hu 
and Becker 2003). Microdialysis studies found that cocaine sensitization is associated 
with augmented DA overflow in response to psychostimulants in striatum and NAc 
(Torregrossa and Kalivas 2007). This hypothesis has not yet been tested in vivo in 
females. Furthermore, striatum is sexually dimorphic and is modulated estradiol (Becker 
1999). This experiment was designed to compare the AMPH-induced DA increase in 
dialysate from striatum after cocaine sensitization among CAST male, OVX female and 
estradiol-treated OVX female rats to see if sex difference in behavioral sensitization 
could be accounted for by a difference of sensitivity of DA system developed with 
repeated cocaine treatment. I hypothesized that there would be augmented AMPH-
induced DA release in striatum after cocaine sensitization in both males and females. This 
changes, however, would show sexually dimorphic patterns and be further modulated by 












EFFECT OF ESTRADIOL ON BEHAVIORAL 
SENSITIZATION TO COCAINE IN FEMALE RATS 
1. Introduction 
Behavioral sensitization is defined as the progressive enhancement of drug- induced 
psychomotor activity after repeated treatment with drugs such as cocaine and 
amphetamine (AMPH) (Robinson and Becker 1986b; Robinson and Berridge 1993; 
Stewart and Badiani 1993). Behavioral sensitization is of interest to the study of drug 
abuse because the same neural substrate that mediates drug addiction may be involved 
(Robinson and Berridge 1993; 2000a; 2001; Wise and Bozarth 1987).  
Patterns of cocaine use have been reported to differ between men and women (Brady 
and Randall 1999; Griffin et al. 1989). For example, women report a greater level of 
cocaine cue-induced craving and a greater level of anxiety after cocaine use (Kosten et al. 
1996; Robbins et al. 1999). The transition from initial use to addiction is shorter in 
women (Kosten et al. 1996). Better treatment outcomes are observed in cocaine 
dependent women compared to cocaine-dependent men in six-month follow-up studies 
(Kosten 1993; Weiss et al. 1997). 
Besides these differences in behavior, cocaine-dependent men and women exhibit 
different patterns of region-specific blood flow as well as stress-induced brain activity, 
which suggests that the neural mechanism underlying cocaine addiction may differ 
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between men and women (Li et al. 2005; Tucker et al. 2004).  
Consistent with clinical studies, sex differences in cocaine-related effects have also 
been reported in rodents, including cocaine-induced locomotor activity, conditioned 
rewarding effects and cocaine self-administration (Becker and Hu 2008; Becker et al. 
2001; Caine et al. 2004; Dalton et al. 1986; Hu et al. 2004; Lynch and Taylor 2005; Russo 
et al. 2003b; Thompson et al. 1984; Walker et al. 2001). Of particular relevance here is 
the sex difference in susceptibility to sensitization (Robinson and Becker 1986b). 
Gonadal hormones, in particular estradiol, have been shown to enhance behavioral 
sensitization to cocaine in female rats (Chin et al. 2002; Hu and Becker 2003; Sircar and 
Kim 1999; Yang et al. 2007). It is not clear, however, whether estradiol modulates the 
neural processes occurring with the development of cocaine sensitization, or just 
produces an activational effect on sensitized brain, or do both to enhance cocaine 
sensitization 
Behavioral sensitization to cocaine can be measured in two ways: 1) demonstration 
of the development of an enhanced psychomotor activating effect of cocaine with 
repeated injection of cocaine by within subject comparison, and/or 2) demonstration of a 
greater behavioral response to cocaine compared to saline-pretreated rats, on a challenge 
day that occurs following withdrawal from cocaine. Looking at the behavioral response 
on the challenge day also allows the investigators to determine the persistence of the 
sensitized response.  
Until now, no research on hormonal influences on cocaine sensitization has tried to 
differentiate or compare the effect of estradiol given during the development of 
sensitization vs. the effect of estradiol on the challenge day. For example, many groups 
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have implanted estradiol-filled silastic capsules throughout the whole experiment (Febo 
et al. 2003; Peris et al. 1991; Perrotti et al. 2001), while others have looked at the effect 
of injections of estradiol prior to treatment with cocaine during the development of 
sensitization (Hu and Becker 2003). In that particular study, 5, 10 or 20 mg/kg cocaine-
induced behavioral sensitization was enhanced by estradiol treatment. On the challenge 
day, this enhanced behavioral response was induced again by 10 mg/kg cocaine, 10 days 
after withdrawal from drug and hormone.  
The present study was designed to determine the effect of estradiol during repeated 
cocaine treatments vs. the effect of estradiol on behavioral sensitization to cocaine as 
demonstrated by behavior on the challenge day. These data could provide insight as to 
whether estradiol is acting to modify the changes in the brain induced by repeated 
cocaine treatments or is affecting the acute effect of cocaine on behavior, or both. More 
importantly, it could guide clinical studies and help develop hormone-based treatments of 
cocaine abuse for women.  
 
2. Materials and Methods 
Animals 
Female Sprague-Dawley rats (Harlan, Indianapolis, IN), weighing 225-250 g at the 
start of the experiment, were housed 3-4 per cage when they arrived. The room had a 
10:14 h dark:light cycle (lights on at 5:30 am and off at 7:30 pm). The animals were 
housed in a room maintained at a constant temperature of 20-21 °C, with free access to 
phytoestrogen-free rodent chow (2014 Tekad Global, 14% protein rodent maintenance 
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diet, Harlan rat chow; Harlan Teklad, Madison, WI) and water available ad libitum. All 
procedures were performed according to a protocol approved by the University of 
Michigan Committee for Use and Care of Animals.  
Ovariectomy (OVX) 
All rats received bilateral ovariectomization surgery (OVX) approximately one week 
after they arrived. During the surgery, an incision around 1 cm long was made on the 
back skin along the midline just below the ribs. The muscle immediately under the skin 
was opened (0.5cm long and 1.5cm lateral to the midline) and the ovary on one side was 
then externalized with blunt forceps. The tissue between the ovary and uterus was 
clamped with a hemostat when the ovary was removed. The hemostat remained in place 
for another 30 seconds until there was no bleeding when the tissue was released and 
returned to the abdomen. The same procedure was repeated on the other side. The wound 
was closed with 11 mm wound clips. All animals underwent vaginal lavage testing daily 
for 10 consecutive days to confirm the cessation of cycling.  
Behavior Sensitization 
Two weeks after OVX surgeries, the rats were assigned to one of four treatment 
groups: (1) saline and 0.1 ml peanut oil; (2) 15 mg/kg cocaine and 0.1 ml peanut oil; (3) 
saline and 5 μg estradiol benzoate (EB) in 0.1 ml peanut oil; (4) 15 mg/kg cocaine and 
EB.  
The testing chamber is a red round chamber (bottom diameter: 41cm; top diameter: 
50cms; height: 42 cm) with a cone (bottom diameter: 16cm; height: 42 cm) in the middle, 
that allowed the rat to move freely around the cone. Animals were injected with EB or oil 
subcutaneously (s.c) and were placed in the testing chamber. After a 30 min habituation 
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period, each rat received an intraperitoneally (i. p.) injection of either saline or 15 mg/kg 
cocaine and was then put back to the testing chamber for one hour. Animals were tested 
for four days per week with three days off for three consecutive weeks, for a total of 12 
testing days (Hu and Becker 2003). No cocaine or saline treatments or hormone were 
administered on the 3 days off. Intermittent treatment was used because it was better at 
producing behavioral sensitization than continuous treatment (Robinson and Becker 
1986b). 
The activity was monitored on day 1(first day of the 1st week), day 8 (first day of the 
2nd week), day 15 (first day of the 3rd week) and day 18 (last day). On the above 
recording days, digital cameras were mounted on the top of each chamber that 
automatically tracked rats’ activity. Behavior was analyzed by the Any-Maze system 
(Stoelting Inc, Wood Dale, IL 60191). On days when behavior was recorded, animals 
were allowed to habituate to the apparatus for 30 minutes as usual; they were then given 
5 mg/kg cocaine or saline injections (i.p.) and put back in the testing chamber for one 
hour. Following that, they received 15 mg/kg cocaine or saline injections and were placed 
in the testing chamber for one hour.  
The challenge day was the 14th day after the last treatment. Each of the four 
treatment groups were further divided into two groups, which either got EB or Oil 
treatment 30 minutes before they got cocaine. All of the rats received 5 mg/kg cocaine 
i.p., and their activities in the chamber were tracked for 60 minutes. This experiment was 
completed in two waves. During the second wave, an additional dose was added with 
another 60 minutes testing to track rat’s locomotor activity induced by 15 mg/kg cocaine 
injections after the 5mg/kg dose on challenge day. See Table 3.1 for a summary of the 
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treatment of each group. 
 
Table 2.1 Experimental design and sample size 
Initial treatment Oil EB 
Drug Saline Cocaine Saline Cocaine 
Challenge day Oil EB Oil EB Oil EB Oil EB 
N 8 8 7 7 8 9 7 6 
 
Statistics 
Data were subjected to analysis of variance (ANOVA) and Student’s t test. 
Differences were considered significant if p < 0.05. All data were analyzed using SPSS 
11.5 for PC.   
 
3. Results 
Development of behavioral sensitization 
During the development of behavioral sensitization, there are only four treatment 
groups: Oil-treated saline (OS) and cocaine (OC) groups as well as EB-treated saline (ES) 
or cocaine group (EC), Distance traveled in the activity chamber during the first 30 
minutes after cocaine (5 mg/kg) or saline injections was used to assess cocaine-induced 
locomotor activity. The behavioral activation on day 1, 8, 15 and 18 is shown in Figure 
2.1. Repeated measures ANOVA analyses found an interaction among time, drug and 
hormone (F (3,162) =3.571 p=0.015). When behavior on each individual day was 
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compared by two way ANOVA (drug x hormone), cocaine treatment significantly 
enhanced locomotor activity compared to saline treatment on each testing day (significant 
effect of drug, p<0.0001 for all four days). There was no effect of EB on either cocaine- 
or saline-induced response on day 1 (F (1, 54) =0.05, p=0.825) or day 8 (F (1, 54) =0.851, 
p=0.360). Estradiol treatment, however, interacts with drug treatment on days 15 (F (1, 
54) =13.641, p=0.001) and 18 (F (1, 54) =9.418, p=0.003). Student t-test was then carried 
out to do individual comparisions. Estradiol not only enhanced the locomotor activity in 
response to low dose of cocaine on day 15 (t (26) =2.66, p=0.014) and day 18 (t (26) 
=2.364, p=0.027), but also decreased the locomotor response in saline rats on day 15 (t 
(32) =3.004, p=0.005) and day 18 (t (32) =2.40, p=0.023).  
 
Figure 2.1: Cocaine- or saline-induced locomotor activity (Mean + SEM) over 30 
minutes of each testing of four testing days (day 1, 8, 15 and 18). The *** indicates 
significant difference in locomotor activity between cocaine-pretreated rats and 
saline-pretreated rats on that testing day. The # indicates significant difference in 
locomotor activity between EB-treated cocaine with oil-treated cocaine groups, or 
between EB-treated saline with oil-treated saline groups. OS: oil treated saline rats 
(n=17); ES: EB treated saline rats (n=16); OC: oil treated cocaine rats (n=14); EC: 
EB treated cocaine rats (n=13).  
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The difference in the distance traveled by the rats on day 18 minus day 1 was taken 
as an index of sensitization (Figure 2.2). Both of the two cocaine-pretreated groups were 
sensitized as the rats’ response to cocaine on day 18 minus day 1 were significantly 
greater than 0 (EC group: t (12) =5.102, p<0.0001; OC group: t (13) =2.151, p=0.05). 
Neither saline group exhibited sensitization or habituation (ES group: t (15) =-1.523, 
t=0.149; OS group: t (16) =1.052, p=0.309). Estradiol significantly enhanced behavioral 
sensitization to cocaine (significant difference between EC and OC group, t=2.74, 
p=0.011), but had no effect on activity induced by repeated saline treatment (no 
significant difference between ES and OS group, t=1.87, p=0.071) 
 
Figure 2.2: The differences of distance (Mean + SEM) traveled by the rats between 
day 18 and day 1(distance traveled by the rats on day 18 after cocaine or saline 
injections minus the distance traveled on day 1 after the same cocaine or saline 
injections for each groups). The *** (p<0.0001) and * (p=0.05) indicate changes in 
locomotor activities are significantly different from 0. The # indicates significant 
difference between OC and EC group. 
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Locomotor activity induced by 5mg/kg cocaine on challenge day 
Cocaine-induced locomotor activity on the challenge day is shown in Figure 2.3 
Three-way ANOVA (prior drug treatment X prior hormone treatments X hormone on 
challenge day) indicates a significant effect of prior drug treatment (F (1, 53) =117.409, 
p<0.0001), suggesting cocaine pretreatment resulted in behavioral sensitization on the 
challenge day. For all the cocaine groups, two way ANOVA (prior EB treatment given 
with repeated cocaine treatment x EB treatment on challenge day) indicated a significant 
interaction ( F(1,23)=6.08, p=0.022). LSD Post Hoc test showed that OE group exhibited 




























Figure 2.3: Locomotor activity (Mean + SEM) over 30 minutes after 5mg/kg cocaine 
injections on challenge day. The *** indicates significant difference in locomotor 
activity between saline-pretreated rats and cocaine-pretreated rats at p<0.0001. The 
* indicates significant difference between cocaine-pretreated OO and OE group. 
Saline-pretreated groups: OO (n=6), OE (n=6), EO (n=8); EE (n=9); Cocaine-
pretreated groups: OO (n=7), OE (n=7), EO (n=7), EE (n=6). 
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Locomotor activity induced by 15mg/kg cocaine on challenge day 
Since EB treatment during development of sensitization failed to enhance behavioral 
activation after 5 mg/kg cocaine injection on challenge day, we hypothesized that a 
higher dose of cocaine might be needed to see the effect of EB. As illustrated in Figure 
2.4 below, 15 mg/kg cocaine caused significant behavioral activation even on the first 
injection, as illustrated by substantial locomotor activity in saline-pretreated rats. Cocaine 
pretreatment resulted in behavioral sensitization in response to 15 mg/kg cocaine 
injection as well, shown by significant effect of drug pretreatment on locomotor activity 
over one hour F(1,30)=4.492, p=0.042.  
All the rats exhibited a higher rate of locomotor activity immediately after the 15 
mg/kg cocaine injection and then slowed, their behavior during the period 15 to 45 min 
exhibited more between-group variations and therefore were analyzed separately. For the 
four groups of cocaine-pretreated rats, two way ANOVA (previous EB treatment given 
with repeated cocaine treatment x EB treatment on challenge day) indicated that previous 
EB treatment given with repeated cocaine treatment significantly enhanced the cocaine-
induced behavioral activation on challenge day (F (1, 14) =8.436, p=0.012). In addition, 
the four groups of saline-pretreated rats do not show any difference in cocaine-induced 



























































Figure 2.4: Locomotor activity (Mean + SEM) induced by 15 mg/kg cocaine on 
challenge day. Distance traveled in 15 min segments over an hour for each group is 
shown in the top panel. Total activity over an hour was compared between all saline-
pretreated rats and all cocaine-pretreated rats in the bottom panel. The * indicates 
cocaine-pretreated rats exhibited significant greater locomotor activity than saline-
pretreated rats. OOS (n=6), OES (n=5), EOS (n=4), EES (n=4), OOC (n=5), OEC 































Figure 2.5: Traveled distance (mean + SEM) over 30 minutes (from 15 to 45 min) 
after 15 mg/kg cocaine injections on challenge day. The * indicates cocaine-
pretreated rats received EB with repeated cocaine treatment exhibited greater 
behavioral activation on change day than did cocaine-pretreated rats received Oil 
with repeated cocaine treatment.  
4. Discussion 
This is the first study investigating the effect of estradiol treatment during 
sensitization vs. post sensitization on the challenge day. In this experiment, estradiol 
enhanced behavioral sensitization to cocaine when it was given with repeated cocaine 
treatments as predicted. More importantly, by comparing behavioral activation post 
sensitization on challenge day with or without another estradiol treatment, it was found 
that estradiol acutely enhanced cocaine-induced behavioral activation in cocaine-
pretreated rats when it was given on the challenge day, suggesting for the first time that 
estradiol produce activational effect on sensitized brain to enhance behavioral activation.  
In addition, the rast that received prior estradiol treatment with repeated cocaine 
treatments, which exhibited greatest behavioral sensitization, also showed enhanced 
cocaine-induced behavioral activation post sensitization on challenge day with or without 
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another estradiol treatment, suggesting estradiol may have also influenced the neural 
sensitization associated with repeated cocaine treatment.  
The present study is consistent with previous reports and supports the idea that 
estradiol promotes cocaine sensitization in female rats (Becker et al. 2001; Chin et al. 
2002; Hu and Becker 2003; Peris et al. 1991; Perrotti et al. 2001; Sell et al. 2002; Sircar 
and Kim 1999; Zhen et al. 2007). Although this question has been addressed by a few 
studies, people differed in the ways of quantifying sensitization. In most studies, people 
compared the absolute amount of behavior induced by cocaine at the end of sensitization 
to determine the magnitude of sensitization. Sensitization, however, is the change of the 
behavior with repeated treatment of drugs, rather than the absolute behavior exhibited. If 
one compares the changes of behavior (day 18 - day 1) for each group, estradiol treatment 
significantly enhanced this change, demonstrated behavioral sensitization as others have 
shown.  
Only one paper has looked at the persistence of estradiol-produced enhanced 
sensitization (Hu and Becker 2003). Estradiol treated OVX rats continued to exhibit 
greater rotational behavioral in response to 10 mg/kg cocaine than OVX rats when they 
were challenged after 10 days’ withdrawal from cocaine and estradiol. Consistent with 
that observation, when a high dose of cocaine was administered in this study, the rats 
with previous estradiol treatment and repeated cocaine treatments exhibited more 
locomotor activity than control rats. Thus, this finding as well as Hu’s study both 
suggests that estradiol, given during cocaine sensitization, may have influenced the 
neural processes associated with sensitization so that the rat continued to show greater 
behavioral activation later on even without circulating estradiol (Hu and Becker 2008).  
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One caution should be kept in mind is that prior EB treatment given with repeated 
drug treatment didn’t significantly interact with repeated drug treatment to influence 
behavior on challenge day in this study. Thus it is possible that the enhanced behavioral 
activation on challenge day seen in the rats that received both prior repeated estradiol and 
cocaine treatment is only due to a long term effect of estradiol. It is known that estradiol 
could produce profound changes on DA system. For example, OVX increase DA and its 
metabolites in the striatum and NAc (Bitar et al. 1991, Shimizu, 1993 #689), decrease 
DAT density in the striatum(Bosse et al. 1997; Le Saux and Di Paolo 2006; Morissette 
and Di Paolo 1993a) and all those effects could be reversed by estradiol treatment. 
Moreover, chronic estradiol treatment has also been shown to act on ERβ to increase D2 
receptor density in the striatum and NAc in OVX rats (Di Paolo 1994; Lammers et al. 
1999; Landry et al. 2002; Le Saux et al. 2006; Zhou et al. 2002). None of the above 
effects of estradiol, however, is known to persist for two weeks after withdrawal from 
estradiol. Compared to that, repeated cocaine treatment is known to produce series of 
long term neuroadaptations in DA system that can persist from weeks to months after 
withdrawal from cocaine (Thomas et al. 2008). Thus, the enhanced behavioral activation 
in the rats treated with repeated estradiol and cocaine compared to the rats that received 
oil and cocaine are more likely due to an interaction of estradiol and cocaine. None the 
less, more studies are needed to confirm this hypothesis.  
Consistent with previous reports from our lab and some other reports, we didn’t see 
an acute effect of estradiol on the locomotor activity after first injection of cocaine in this 
study (Hu and Becker 2003; Peris et al. 1991; Perrotti et al. 2000; Sircar and Kim 1999; 
Yang et al. 2007). A role for estradiol, however, has been reported in several other studies 
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when estradiol benzoate-filled silastic capsules were implanted early before the 
testing(Perrotti et al. 2001; Quinones-Jenab et al. 2000; Sell et al. 2000). The differential 
effect may be due to short vs. long exposure to estradiol.  
Even though estradiol did not enhance the response to the first cocaine treatment, 
previously sensitized rats exhibited an enhanced behavioral response when pre-treated 
with estradiol acutely on challenge day. Thus, when an animal has been sensitized, 
estradiol exacerbates this effect. The expression of behavioral sensitization is suggested 
to be related to the enhanced DA transmission in NAc and striatum (Vezina 2004). 
Moreover, estradiol produces rapid effect on DA transmission in striatum. For example, 
an acute administration of estradiol to OVX rats induce a rapid increase in AMPH-
induced DA release in striatum in vivo (Becker 1990b), induces an increase in striatal DA 
turnover (Di Paolo et al. 1985) and decrease D2 class DA receptors (Bazzett and Becker 
1994). Thus, it is very likely that sensitized DA transmission in striatum after cocaine 
sensitization made the acute effect of estradiol more pronounced to result in behavioral 
effect that was not seen before sensitization. More importantly, this effect of estradiol on 
challenge day is probably simply due to its enhancement of cocaine-induced increases in 
DA neuron reactivity, which is independent of the neural processes mediating 
sensitization. 
An intriguing thing is no acute effect of estradiol was seen if the rats received prior 
administration of cocaine as well as estradiol. Note that those animals showed most 
robust behavioral sensitization during the development of sensitization, it is possible that 
ceiling effect prevented us from seeing additional acute effect of estradiol. Moreover, if 
previous long term estradiol treatment has interacted with cocaine and produced some 
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long term effect on DA system as I pointed out earlier, the way of DA transmission in 
response to estradiol may have been comprised or changed.  
Another observation in this study is estradiol decreased the activity in saline rats at 
later stage of sensitization. It might be due to anti-depressant and anti-anxiety effect  of 
EB (Walf and Frye 2005a; b; 2006; 2007a; b; Walf et al. 2004). When the rats face novel 
environment, however, estradiol is also known to enhance spontaneous locomotor 
activity (Becker et al. 1987; Frye et al. 2000; Morgan and Pfaff 2001; 2002), which may 
explain why initial response to saline was comparable between estradiol- and oil- treated 
rats.   
In conclusion, this study demonstrated that estradiol treatment enhances behavioral 
sensitization when given during cocaine treatment as predicted. Importantly, it provides 
the first evidence suggesting that estradiol can produce activational effect on sensitized 
brain to enhance behavioral activation in cocaine-sensitized rats. Moreover, prior 
estradiol treatments, given with repeated cocaine treatment, resulted in greater behavioral 
activation in response to a high dose of cocaine on challenge day after two weeks 
withdrawal from cocaine and hormone, suggesting estradiol may have also influenced the 
neural sensitization occurred with repeated cocaine treatment. More experiments are 
needed to further clarify each mechanism, which are important for developing 








EFFECT OF ESTRADIOL AND COCAINE 
SNESITIZATION ON COCAINE SELF-ADMINISTRATION 
1. Introduction 
Cocaine abuse is an important health issue throughout the world. Among all illicit 
drugs, it has second highest level of dependence among all the illicit drugs in National 
Survey on Drug Use and Health (SAMHSA 2007). Understanding the underlying 
mechanisms mediating cocaine use and abuse is important for developing clinical 
treatment and prevention.  
Cocaine self-administration in rodents has been widely used as a preclinical model 
of cocaine use in humans. Interestingly, in laboratory animals, as seen in humans, there 
are individual differences in drug taking behavior. Factors such as stress, individual 
characteristics and prior drug history have been shown to modulate the vulnerability to 
self-administer cocaine-like psychomotor stimulants (Davis et al. 2008; Fattore et al. 
2008; Piazza et al. 1989; 1990).  
Of particular interest here is how prior experience with psychomotor stimulants 
modulates the vulnerability to self-administer them. It has been shown that behavioral 
sensitization either induced by stress or repeated amphetamine (AMPH) treatment 
predisposes rats to self-administer low dose of AMPH (Piazza et al. 1989; 1990). Animals 
that have been previously sensitized to AMPH also acquire cocaine self-administration 
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faster (Horger et al. 1992; Valadez and Schenk 1994), accelerate escalation of cocaine 
intake when they are given extended access to cocaine self-administration (Ferrario and 
Robinson 2007). Similarly, rats that are pre-exposed to cocaine learn self-administration 
faster and develop a preference to a dose of cocaine that non-exposed rats do not prefer 
more than saline (Childs et al. 2006; Horger et al. 1990). All of these suggest prior 
exposure to psychostimulants may have enhanced the reinforcing effect of 
psychostimulants. 
Midbrain dopamine (DA) neuron reactivity, which mediates both stimulant and 
reinforcing effect of psychostimulants, is reported to be sensitized by repeated exposure 
to psychomotor stimulant drugs (Torregrossa and Kalivas 2007). Moreover, reactivity of 
DA neurons is directly related to self-administration of psychomotor stimulant drugs 
(Vezina 2004). Thus, sensitization to cocaine or AMPH may enhance the reinforcing 
effect of these drugs through a sensitized dopaminergic system, and therefore promote 
self-administration (Vezina 2004).  
In all the studies discussed above, males were used as subjects. The relationship of 
sensitization and self-administration has not been examined in females. Clinical studies 
suggest a gender difference in response to cocaine as cocaine cues induce more cocaine 
craving in female than male addicts (Robbins et al. 1999). Women also report less 
pleasure and dysphoria and greater anxiety in response to cocaine (Kosten et al. 1996; 
Lukas et al. 1996; Singha et al. 2000). Female substance users have greater cocaine use 
and are more likely to be dependent on cocaine than males (Lejuez et al. 2007). Further 
more, women cocaine addicts report greater subjective effect of smoked or intravenous 
cocaine administration in the follicular phase than in the luteal phase, which suggest a 
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role of ovarian hormones on cocaine-induced response (Evans et al. 2002; Sofuoglu et al. 
1999).  
In accordance with clinical studies, rodents also show sex differences in response to 
cocaine. Female rats acquire cocaine self-administration more rapidly and self-administer 
more cocaine than do male rats (Hu et al. 2004). They are more sensitive to the priming 
effect of cocaine during reinstatement (Lynch and Carroll 2000). Female rats also show 
greater behavioral sensitization than male rats (Hu and Becker 2003). Moreover, females’ 
self-administration behavior fluctuates over the estrous cycle (Lynch et al. 2000; Roberts 
et al. 1989). Further investigation suggests that estradiol enhances the acquisition of 
cocaine self-administration and cocaine intake in female rats (Hu et al. 2004; Lynch et al. 
2001).  
Related to above behavioral difference, ascending midbrain DA projections, which 
are known to mediate psychomotor stimulant and reinforcing effect of cocaine, are also 
sexually dimorphic and modulated by estradiol (Becker 1999). Only one study has ever 
looked at the striatal DA reactivity after cocaine sensitization in females, and reported 
that the DA release from striatum in vitro was enhanced after cocaine pretreatment (Peris 
et al. 1991). Nobody has ever tested if cocaine pretreatment also results in enhanced DA 
dopamine (DA) release in vitro from nucleus accumbens (NAc) in females.  
This study was designed to investigate the effects of cocaine sensitization on cocaine 
self-administration in female rats. Moreover, from the previous sensitization experiment 
(chapter II), we saw that acute estradiol enhanced behavioral activation in cocaine-
sensitized rats. Thus we also investigate whether estradiol further enhance cocaine self-
administration in cocaine-sensitized rats. Lastly, we test the hypothesis that cocaine 
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experience results in enhanced release of DA from both the nucleus accumbens and 
dorsal striatum in an in vitro superfusion experiment.  
2. Materials and Methods 
Animals 
Female Sprague-Dawley rats (Harlan, Indianapolis, IN), weighing 225-250 g at the 
start of the experiment, were housed 3-4 per cage when they arrived. The room has a 
10:14 h regular dark:light cycle (lights on at 5:30 am and go at 7:30 pm). The animals 
were housed in a room maintained at a constant temperature of 20-21 °C, with free access 
to phytoestrogen-free rodent chow (2014 Tekad Global, 14% protein rodent maintenance 
diet, Harlan rat chow; Harlan Teklad, Madison, WI) and water available ad libitum. All 
procedures were performed according to a protocol approved by the University of 
Michigan Committee for Use and Care of Animals.  
 
Ovariectomy  
All rats were bilaterally ovariectomized (OVX) approximately one week after they 
arrived. During the surgery, an incision around 1 cm long was made on the back skin 
along the midline just below the ribs. The muscle immediately under the skin was opened 
(0.5 cm long and 1.5 cm lateral to the midline) and the ovary on one side was then 
externalized with blunt forcepts. The tissue between the ovary and uterus was clamped 
with a hemostat when the ovary was removed. The hemostat was remained in place for 
another 30 seconds until there was no bleeding when the tissue was released and returned 
to the abdomen. The same procedure was repeated on the other side. The wound was 
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closed with 11 mm wound clips. All animals underwent vaginal lavage testing daily for 
10 consecutive days to confirm the cessation of cycling.  
8 rats were randomly selected as cocaine naïve control group and kept in the home 
cages until they were sacrificed for the superfusion experiment. All other animals were 
assigned to one of the four treatment groups: (1) rats received saline treatment during 
sensitization and oil treatment during self-administration (SO, n=12); (2) rats received 
saline treatment during sensitization and EB (5µg estradiol benzoate dissolved in 0.1 ml 
peanut oil) treatment during self-administration (SE, n=14); (3) rats received cocaine 
treatment during sensitization and oil treatment during self-administration (CO, n=12); 
(4) rats received cocaine treatment during sensitization and EB treatment during self-
administration (CE, n=14).  
Cocaine Sensitization 
The testing chamber is a round chamber (bottom diameter: 41cm; top diameter: 
50cms; height: 42 cm) with a cone (bottom diameter: 16cm; height: 42 cm) in the middle, 
which allowed the rat to move freely around the cone. Two weeks after OVX surgeries, 
animals received an injection of 0.1 ml oil subcutaneously and placed in the testing 
chamber. After a 30 min habituation period, each rat received an intraperitoneally (i.p) 
injection of either saline or 15 mg/kg cocaine (according to their treatment group) and 
was then put back into the testing chamber for one hour. Animals were tested for four 
days per week, followed by three days off, for three consecutive weeks, for a total of 12 
testing days (Hu and Becker 2003). No cocaine or saline were administered on the 3 days 
off. Intermittent treatment was used here because it was better at producing behavioral 
sensitization than continuous treatment (Robinson and Becker 1986b). 
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The activity was monitored on day 1 (first day of the 1st week), day 8 (first day of 
the 2nd week), day 15 (first day of the 3rd week) and day 18 (last day). On the above 
recording days, digital cameras were mounted on the top of each chamber to 
automatically tracked rats’ activity. Behavior was analyzed by the Any-Maze system 
(Stoelting, Inc. Wood Dale, IL). On days when behavior was recorded, animals were 
allowed to habituate to the apparatus for 30 minutes as usual; they were then given 
5mg/kg cocaine or saline injections (i.p.) and put back in the testing chamber for one hour. 
Following that, they received 15 mg/kg cocaine or saline injections and were placed in 
the testing chamber for one hour. On those four days, cameras were mounted on the top 
of each bucket to videotape and monitor the activity of the rats throughout the testing. 
Animals’ behavior was quantified by the Any-Maze system. 
 
Catheter implantation 
10 days after sensitization training, rats were prepared with indwelling intravenous 
jugular catheters connected to a backport. Catheters were constructed by gluing Silastic 
tubing (0.51mm ID, 0.94 mm OD; Dow Corning, Midland, MI) to an external guide 
cannula. The cannulae were then glued to polypropylene mesh with cranioplastic cement.  
Rats were anesthetized with a combination of ketamine (45 mg/kg, i.p.) and 
medetomidine (0.3 mg/kg, i.p.). The free end of the Silastic tubing was inserted into the 
right jugular vein and secured with 4.0 silk sutures around the venous tissue. The 
catheters exited dorsally on the animal’s back. Dummy stylets were inserted into the 
catheters when rats were not connected to infusion pumps. Catheters were flushed daily 
with 0.1 ml heparinized saline (30 U/ml, in 0.9% sterile saline buffered at pH 7.4) and a 
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0.1 ml gentamicin solution (0.8 mg/ml) to prevent occlusions and to circumbent 
microbial buildup in the catheter. 
For each self-administration session, catheters were flushed with 0.1 ml of saline 
before sessions began and with 0.1 ml gentamicin after session ended.  
Cocaine self-administration 
Self-administration apparatus is a standard operant chamber (25 x 27 x 30 cm) that 
was placed in a sound-attenuating cabinet (Med Associates, Inc., Georgia, VT). There 
were a red house light, a tone generating apparatus, and two nose-poke holes in each 
chamber. Rats were connected to an infusion syringe and tethered via a steel cable to a 
swivel. The swivel was mounted on a counterbalanced arm so that the animal can move 
freely in the test cage. The infusion pumps were mounted on the outside doors of the 
cabinets. At the start of the experiment, the red house lights were illuminated and 
remained on for the whole session so that the rat’s behavior could be monitored through 
the observer’s camera on the cabinet door. Nose poke on the active hole resulted in an 
intravenous injection of 50 µl of cocaine-HCl in saline delivered over 2.8 s. This process 
was accompanied by a compound stimulus consisting of a white stimulus light and a tone 
(85 dB). There was a 5 s time-out period after each infusion, during which time further 
nose pokes had no programmed consequences. But nose pokes were still recorded. Nose 
pokes in the inactive hole were also recorded, but had no programmed consequences.  
17 days after the last treatment with cocaine or saline (around five days after 
recovery from catheter surgery), rats began cocaine self-administration. Rats received 
either EB or Oil (s.c), according to their treatment group, 30 min before self-
administration session started. Rats were allowed to nose poke to obtain an i.v. infusion 
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of cocaine on an FR1 schedule of reinforcement. The self-administration test occurred 
five days per week with two days off for four weeks. No cocaine or saline treatment or 
hormone was administered during the two days off. The doses of cocaine that was self-
administered during each week were 0.1, 0.1, 0.15, 0.4 mg/kg/infusion. The test session 
last 120 min every testing day during the first three weeks and 60 min during the last 
week. We reduced the session time in the last week to prevent overdose. Rats didn’t 
receive any training for nose poking and they were not primed with cocaine.  
Superfusion 
Due to a limit in the number of chambers that could be tested with the superfusion 
apparatus (Brandel Inc., Gaithersburg, Md., USA) each day, only brains from CE group 
and the 8 cocaine naïve rats that had been kept in the home cage since OVX surgeries, 
were used for superfusion experiment.  
After self-administration testing ends, animals in CE group were given 15 mg/kg 
cocaine treatment (i.p.) every day for another four days to reduce variability of cocaine 
experience during self-administration. Ten days after the last cocaine treatment, they got 
one i.p. injection of low dose cocaine (5 mg/kg) and locomotor activity was monitored. 
Brains were obtained for superfusion experiment three to four days after the cocaine 
challenge.  
Superfusion experiments were performed using an automated superfusion system 
(Brandel Inc., Md., USA). The procedure used was as described previously (Xiao et al. 
2003). On the day of superfusion, a Ringer’s solution was oxygenated by bubbling with 
95%O2/5%CO2 for at least 30 min and the pH was adjusted to 7.4 in the morning. 
Animals were decapitated, and the brain was removed and placed in ice-cold Ringer’s 
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solution within 5 mins. The dorsal striatum and ventral striatum (including NAc and 
medial olfactory tubercle) was dissected from each rat separately. Each brain region was 
cut into approximately 0.5 to 1 mm3 fragments and placed into different superfusion 
chambers filled with Ringer’s solution. The brain fragments were allowed to equilibrate 
for 60 mins before sample collection while Ringer’s solution flowed at 100 μl/min. 
Following the stabilization period, two 5-min baseline samples were collected. Then a 10 
µM d-AMPH was delivered to all the chambers for 2.5 min followed by continuously 
delivery of the Ringer’s again. Effluent samples were collected every 5 minutes 
throughout the whole experiment. The solutions were warmed to 37°C via water bath 
prior to reaching the chambers and the chambers were warmed in a water bath at 37°C. 
Each collection vial contained 25 µl of 0.05 N HClO4 with dihydroxybenzylamine as an 
internal standard to control for any variation in volume and loss of DA due to oxidation. 
Tissue in each chamber was removed and weighed immediately following the 
superfusion. The amount of DA in each sample was measured by the HPLC-ED (ESA 
Biosciences, Inc. Chelmsford, MA, US). 
Statistics 
Data were subjected to analysis of variance (ANOVA) and Student’s t test. 
Differences were considered significant if p < 0.05. All data were analyzed using SPSS 
11.5 for PC.   
3. Results 
Induction of cocaine sensitization 
The difference in distance traveled over 60 minutes on day 1 vs. day 18 was 
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calculated to assess sensitization (Figure 3.1). As expected, cocaine treatment produced 
behavioral sensitization (t (25) =2.173, p=0.039); and saline treatment resulted in 
behavioral habituation (t (23) =-4.964, p<0.0001).  
 
 
Figure 3.1: Difference in distance traveled (Mean + SEM) after cocaine (5mg) or 
saline injections (day 18 - day 1). The * and *** indicate significant difference from 
0. The # indicates cocaine group was significantly different from saline group.   
 
Acquisition of cocaine self-administration 
Acquisition of cocaine self-administration was defined as when nose poking in the 
active hole was more than 20 per two hour session or more than 10 per one hour session 
for three consecutive days and nose poking in the active hole was more than twice that in 
the inactive hole. This criterion was chosen based on the average number of nose pokes 
in the inactive hole during two hours session for the first week, which was not greater 
than 10. This criterion has been used in other self-administration studies (Hu et al. 2004; 
Jackson et al. 2006). Rats that acquired the cocaine self-administration according to this 
criterion showed a stable increase in cocaine intake over the remaining experiment.  
Fig 3.2 shows the percentage of animals in each group that acquired self-
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administration throughout the experiment. By the end of the first week, half of the rats 
from CE group had already acquired self-administration, whereas only 30% of rats from 
other groups had done so. By the end of the second week, 80% of rats from CE group and 
more than 60% from CO group had acquired self-administration whereas only 40% of 
saline-pretreated animals had done so. On week 3 when the dose increased to 0.15 
mg/kg/inf, all the rats in SE group acquired self-administration, whereas a few rats from 
SO group did so. Some SO animals only acquired self-administration when the dose was 
increased to 0.4 mg/kg/inf during week 4. Chi square analyses showed the acquisition 
curves were different among the four groups, X2(3) =4.432, p=0.0397. Individual 
comparisons between each pair of curves indicated that CE group have different 
acquisition curves compared to SO group, X2(1) =4.586, p=0.032 
 
Figure 3.2: The self-administration acquisition curves of each group. The * indicates 
EC group acquired self-administration faster than OS group. CE (n=12): cocaine-
pretreated rats received EB during self-administration session; CO (n=14): cocaine-
pretreated rats received O during self-administration session; SE (n=12): saline-
pretreated rats received EB during self-administration session; SO (n=12): saline-





















































Figure 3.3 shows the average number of days to acquire self-administration for each 
group. Two-way ANOVA analyses (drug X hormone) indicated a significant effect of 
prior cocaine treatment (F (1, 46) =4.926, p=0.03). 
 











































Figure 3.3: The average days (Mean + SEM) to acquire cocaine self-administration 
for each group. The * indicates prior cocaine treatment significantly accelerated the 
acquisition of cocaine self-administration regardless of hormone treatment.  
 
The total number of cocaine infusion of each week 
When the total number of cocaine infusions per week (Figure 3.4) was examined by 
two-way ANOVA (drug X hormone), prior cocaine treatment greatly enhanced cocaine 
taking behavior during week 2 (F (1, 46)=8.405, p=0.006), week 3 (F(1, 46)=9.672, 
p=0.003) and week 4(F(1, 46)=7.040, p=0.011). Post hoc comparison showed that CE 
group always took more cocaine than SO group (p<0.05).  
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Figure 3.4: Total number of cocaine infusions (Mean + SEM) per week for each 
group of rats. Cocaine sensitization greatly enhanced cocaine self-
administration throughout the whole experiment. The * indicates that CE 
group always took more cocaine then SO group.  
 
For the last 6 self-administration sessions (Figure 3.5), two-way ANOVA indicated 
there was both a main effect of drug pretreatment (F (1, 46) =9.171, p=0.004) and a main 




Figure 3.5: Total cocaine intake over the last 6 sessions for each group (Mean + 
SEM). The * indicated a significant effect of hormone treatment. The # indicated a 
significant effect of drug pretreatment.  
  
Total inactive nose pokes of each week 
To make sure that the treatment did not affect general activity, nose pokes in the 
inactive hole were analyzed (Figure 3.6). There was no significant difference in inactive 
nose pokes among the four groups of rats during the first three weeks. EB treatment, 
however, significantly enhance inactive poking in the last week (F (1, 46) =6.8, p=0.012), 
when the high dose of cocaine was self-administered by the rats.  
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Figure 3.6: Total inactive poking of each week for each group of rats (Mean + SEM). 
The * indicates EB treatment immediately before cocaine self-administration 
resulted in more total inactive poking in week 4 when the dose was 0.4 mg/kg/inf.  
 
Cocaine-induced locomotor activity on challenge day  
The CE group was compared with cocaine naïve rats for analysis of AMPH-induced 
DA (DA) release using in vitro superfusion. EC rats were injected with 5 mg/kg cocaine 3 
to 4 days prior to the superfusion experiment, to determine if they were still sensitized to 
cocaine. Locomotor activity induced by 5 mg/kg cocaine upon first injection and 
challenge injection of cocaine in EC group is illustrated in Figure 3.7. Behavioral 
sensitization to cocaine was seen 10 days after cocaine self-administration (3 to 4 days 





Figure 3.7: Distance traveled (Mean + SEM) by the cocaine rats over 60 mins after 5 
mg/kg cocaine injections on day 1 and challenge day. The * indicated that cocaine 
rats exhibited greater locomotor activity on challenge day than on day 1. 
 
AMPH-induced DA efflux in the dorsal striatum 
The DA efflux (pg/mg) induced by AMPH from the dorsal and ventral striatum 
tissue is shown in Figure 3.8 (the average of two samples collected immediately before 
AMPH application is used as basal DA for each rat). AMPH significantly induced DA 
efflux at 5, 10 and 15 mins in both dorsal and ventral striatum from cocaine rats and 
cocaine-naïve rats (all bars are significantly different from 0 at p=0.05). Furthermore, 
ANOVA analyses indicated cocaine experience interacted with the pattern of DA release 
in both dorsal striatum (F(1,11)=7.077, p=0.022) and ventral striatum (F(1,12)=5.480, 
p=0.037). Student’ t-tests were used to compare DA efflux at each time point between 
groups. There was greater striatal DA release 10 mins post-AMPH in dorsal striatal tissue 
(p=0.05) and 5 mins post-AMPH in ventral striatal tissue (p=0.035) from rats that had 




Figure 3.8: Increase in DA (Mean + SEM) after AMPH application to the dorsal (A) 
and ventral (B) striatum . AMPH induced significant DA efflux (significant different 
from 0) in both dorsal and ventral striatum from cocaine-naïve rats and cocaine rats. 
The * indicated greater DA increase in striatal tissue from cocaine rats than did 





In the present study, we show that prior exposure to cocaine significantly promoted 
the acquisition of cocaine self-administration and cocaine intake in female rats. While 
there were some effects of estradiol to enhance cocaine intake, the effect of prior cocaine 
sensitization was much more powerful than the hormone effect. Importantly, we 
confirmed that sensitization of AMPH-induced DA release in vitro was seen in dorsal and 
ventral striatum from animals after acquisition of cocaine-taking behavior.  
The present finding is consistent with previous reports found that preexposure to 
psychomotor stimulants enhanced self-administration of cocaine or AMPH in male rats 
(Ferrario and Robinson 2007; Horger et al. 1990; Piazza et al. 1989; Pierre and Vezina 
1997; Schenk and Partridge 2000; Suto et al. 2002; Vezina 2004; Vezina et al. 2002). In 
male rats, it has been suggested that both cocaine sensitization and enhanced cocaine self-
administration is a consequence of similar neuroadaptations (Vezina 2004). Either 
behavior can be initiated or promoted by AMPH pretreatment in VTA (Hooks et al. 1992; 
Kalivas and Weber 1988; Suto et al. 2002; Suto et al. 2003; Vezina et al. 2002) and are 
both related to an enhancement of DA transmission in DA terminal area (Akimoto et al. 
1989; Cadoni et al. 2000; Hooks et al. 1994; Kalivas and Duffy 1993; Paulson and 
Robinson 1995; Pierce and Kalivas 1995; Wolf et al. 1993).  
To be specific, in vitro studies have shown that AMPH application to striatal and 
accumbal slices from rats pretreated with AMPH stimulate greater DA release than did 
controls (Castaneda et al. 1988; Kantor et al. 1999; Kolta et al. 1989; Robinson and 
Becker 1982). Enhanced DA transmission in striatum and NAc after AMPH sensitization 
has been demonstrated in vivo as well (Cadoni et al. 2000; Paulson and Robinson 1995; 
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Wolf et al. 1993). Similar to AMPH, prior cocaine treatment enhances AMPH-stimulated 
DA release in striatal tissue (Peris et al. 1990; Peris et al. 1991; Peris and Zahniser 1989). 
An enhancement of psychostimulant-induced increase in DA transmission in NAc as a 
result of cocaine sensitization, however, has only been demonstrated by in vivo 
micordialysis studies (Cadoni et al. 2000; Kalivas and Duffy 1993; Paulson and Robinson 
1995; Pierce and Kalivas 1995). This study not only confirmed there is an enhanced DA 
efflux in striatum in female rats after prior cocaine experience, but also demonstrated that 
cocaine experience leads to similar enhancement in AMPH-induced DA release in NAc in 
vitro. Taken together, it suggests that the same neural adaptations exist in females as well 
and may account for observed behavior in this experiment.  
Even though NAc and striatum share very similar neural characteristics, they are 
mediating different motor components (locomotion vs. stereotypy) activated by 
psychostimulants (Amalric and Koob 1993; Castall et al. 1977; Costall et al. 1977). 
Moreover, NAc, rather than striatum, is found to be the key neural substrate mediating 
the reinforcing effect of psychostimulants. Compared to that, a role for dorsal striatum in 
reinstatement of self-administration was suggested recently (Fuchs et al. 2006; See et al. 
2007; Vanderschuren et al. 2005). In particular, extracellular DA was increased in the 
dorsal striatum rather than the NAc during responding for cocaine-associated cues after 
chronic cocaine self-administration in animals or in cocaine-dependent subjects (Ito et al. 
2000; Ito et al. 2002; Volkow et al. 2006; Wong et al. 2006). Thus, even though reactivity 
of both NAc and dorsal striatum DA neuron is enhanced by cocaine experience, they may 
serve different functions. 
An effect of estradiol at promoting the acquisition of cocaine self-administration and 
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cocaine intake has been previously established with doses between 0.3 to 0.5 mg/kg (Hu 
and Becker 2008; Hu et al. 2004; Jackson et al. 2006). No effect of estradiol on the 
acquisition of cocaine self-administration was seen in this study. It suggests prior cocaine 
experience is much more powerful than estradiol at modulating the acquisition of cocaine 
self-administration.  
Consistent with previous findings, estradiol enhanced cocaine intake during the last 
six test sessions with cocaine doses from 0.15 to 0.4 mg/kg. There was also an effect of 
estradiol on nose pokes in the inactive hole during the last week of self-administration 
with 0.4 mg/kg cocaine. Enhanced nose pokes in estradiol-treated rats may be due to 
enhanced motivation to take drugs or enhanced locomotor activation or both. One thing 
that should be kept in mind is that the animals were mostly at the acquisition stages of 
cocaine self-administration. It is known that sensitization powerfully modulates the 
acquisition of drug self-administration at sub-threshold doses but has no effect on 
acquisition of self-administration or drug intake at high doses (Lorrain et al. 2000). It is 
possible that an effect of estradiol may have emerged as playing a more important role on 
intake after acquisition, if self-administration had been extended for a longer time.  
Even though drug-pretreated and drug-naïve animals are not distinguishable when 
they self-administer high dose of drug with little work demand, they do differ in the 
motivation to take high dose of drugs when the work demands are increased in 
progressive ratio schedule. Animals that have been sensitized work harder to obtain drugs 
than do drug naïve rats (Lorrain et al. 2000; Mendrek et al. 1998). Estradiol is also known 
to enhance females’ motivation to take cocaine as exhibited by higher breaking point on a 
progressive ratio schedule (Becker and Hu 2008). Thus, it remains to be determined 
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whether estradiol and cocaine sensitization interact to influence female rats’ motivation to 
work for high dose of cocaine on a progressive ratio schedule. 
In conclusion, the above study strongly suggests that cocaine sensitization made 
female rats more vulnerable to the effect of cocaine as it promoted the acquisition of 
cocaine self-administration and cocaine intake, as has been seen in male rats. 
Furthermore, prior cocaine experience is much more powerful than estradiol at enhancing 
at acquisition of cocaine self-administration. Associated with cocaine experience, there is 
enhanced AMPH-induced DA release in both ventral and dorsal striatum in vitro. This 
study adds important evidence to the current literature suggesting similar mechanisms 
and relationship between cocaine sensitization and cocaine self-administration exists in 
females as well. Understanding the mechanism underlying these behavioral changes is 
















CHAPTER IV  
PRIOR COCAINE TREATMENT PRODUCES CROSS-
SENSITIZATION TO AMPHETAMINE IN SEXUALLY 
DIMORPHIC PATTERN 
1. Introduction 
Psychomotor stimulant drugs such as amphetamine (AMPH) and cocaine are known 
to produce acute psychomotor activating effect by activating nigrostriatal and mesolimbic 
dopamine (DA) neurotransmission (Hurd and Ungerstedt 1989). When these drugs are 
repeatedly administered, the ability to produce a psychomotor activating effect is usually 
enhanced so that a later challenge administration of those drugs could result in a greater 
psychomotor activating effect, evidenced by a greater psychomotor stimulants-induced 
locomotor activity or stereotype compared to the behavioral activation after first injection 
(Robinson and Becker 1986a; Robinson and Berridge 1993). Accompanying this 
behavioral sensitization, an increase of DA overflow in the nucleus accumbens (NAc) 
and striatum has been observed in sensitized animals both in vitro and in vivo (Kalivas 
and Stewart 1991; Kantor et al. 1999; Pierce and Kalivas 1997; Robinson et al. 1982; 
Robinson and Berridge 1993; Vanderschuren et al. 1999a) and is suggested as an 
important mechanism underlying addiction. 
The above notion is largely based on experimental evidence conducted on male 
rodents. Cocaine and AMPH sensitization, however, is also modulated by sex and ovarian 
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hormones (Chin et al. 2002; Hu and Becker 2003; Robinson and Becker 1986b; Sircar 
and Kim 1999; Yang et al. 2007). Specifically, OVX female rats show greater behavioral 
sensitization to cocaine than CAST male rats, and estradiol further enhance behavioral 
sensitization in OVX female rats (Hu and Becker 2003).  
Related to sex differences in psychostimulant-related responses, sex differences in 
mesostriatal dopamine (DA) function have been reported (Becker 1999). Both basal DA 
levels in vivo and AMPH-stimulated DA release from striatal tissue are higher in CAST 
males compared to OVX females (Becker and Ramirez 1981b; Castner et al. 1993). 
Moreover, basal striatal DA levels fluctuats over the estrous cycle and acute estradiol 
enhances AMPH-induced DA release in OVX female rats (Becker and Rudick 1999; 
Castner et al. 1993; Xiao and Becker 1994). These findings suggest that presynaptic DA 
function in striatum is sexually dimorphic and modulated by estradiol treatment.  
 In terms of sensitization-related neuroadaptations, as in male rats, prior AMPH 
injection or cocaine treatment enhances AMPH-stimulated striatal DA release in females 
in vitro (Peris et al. 1991; Robinson et al. 1982). But no direct comparison between males 
and females has yet been made. Furthermore, in female rats, enhanced AMPH-induced 
DA release from striatal tissue after sensitization is more pronounced in cocaine-
sensitized rats chronically treated with estradiol compared to OVX rats (Peris et al. 1991). 
Until now, no study has examined the effect of cocaine sensitization on reactivity of 
striatal DA neuron in vivo in female rats. In addition, previous work has shown long term 
(12 days) changes in behavioral activation when animals were treated with estradiol 
during cocaine sensitization (Hu and Becker 2003). It is not known if it is related to a 
long term effect of estradiol on neuroadaptations in DA system.  
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This study was designed to compare the AMPH-induced increase of DA in dialysate 
in the striatum after cocaine sensitization among CAST male, OVX female and OVX 
female rats treated with estradiol, to test if there are long term changes in the nigrostriatal 
DA system due to cocaine sensitization in both male and female rats. We also 
investigated whether this change is sexually dimorphic or modulated by estradiol. It was 
hypothesized that there will be enhanced AMPH-induced DA release in striatum after 
cocaine sensitization and this neuroadaptation would differ between male and female rats, 
and be enhanced in OVX rats that received estradiol during sensitization.    
  
2. Materials and Methods 
Animals 
Male and female adult Sprague-Dawley rats (Harlan, Indianapolis, IN), weighting 
225-250 g at the start of the experiment, were housed 3-4 per cage when they arrived. 
The room has a 10:14 h regular dark: light cycle (lights on at 5:30 am and off at 7:30 pm). 
The animals were housed in a room maintained at a constant temperature of 20-21 °C, 
with free access to phytoestrogen-free rodent chow (2014 Tekad Global, 14% protein 
rodent maintenance diet, Harlan rat chow; Harlan Teklad, Madison, WI ) and water 
available ad libitum. All procedures were performed according to a protocol approved by 
the University of Michigan Committee for Use and Care of Animals. 
 
Gonadectomy 
One week after the rats arrived, they all went through gonadectomy surgery under 
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isoflurane anesthesia. All female rats received bilateral ovariectomization (OVX) surgery. 
During the surgery, an incision around 1cm long was made on the back skin along the 
midline just below the ribs. The muscle immediately under the skin was opened (0.5cm 
long and 1.5cm lateral to the midline) and the ovary on one side was then externalized 
with blunt forcepts. The tissue between the ovary and uterus was clamped with a 
hemostat when the ovary was removed. The hemostat remained in place for another 30 
seconds until there was no bleeding, at which time the tissue was released and returned to 
the abdomen. The same procedure was repeated on the other side. The wound was closed 
with 11mm wound clips. All male rats received castration (CAST) surgery. The scrotal 
sac is opened and the testis is externalized. The blood supply to the testis is closed with 
suture material, and the testis is removed. The wound is then closed with wound clips. All 
female animals underwent vaginal lavage testing daily for 10 consecutive days to confirm 
the cessation of cycling. 
 
Cocaine Sensitization 
Two weeks after gonadectomy surgeries, the rats were assigned to one of six groups: 
(1) castrated male rats treated with saline and peanut oil (n=4); (2) castrated male rats 
treated with cocaine and oil (n=4); (3) OVX female rats treated with saline and oil (n=6); 
(4) OVX female rats treated with cocaine and oil (n=5);(5) OVX female rats treated with 
saline and 5 μg estradiol benzoate (EB) dissolved in peanut oil (n=7); (6) OVX female 
rats treated with cocaine and EB (n=8).  
The testing chamber is a square plastic cage (8 inch x 17 inch x 7 inch). Animals 
were injected with either EB or 0.1 ml peanut oil subcutaneously (s.c.), according to their 
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group treatment, and were placed in the testing chamber. After a 30 min habituation 
period, each rats received an intraperitoneally (i.p.) injection of either saline or 20 mg/kg 
cocaine and was then put back to the testing chamber for one hour. Animals were tested 
for five days per week with two days off for three consecutive weeks, for a total of 15 
testing days. No cocaine or saline treatments or hormone was administered on the 2 days 
off. Intermittent treatment was used here because it was better at producing behavioral 
sensitization than continuous treatment (Post 1980; Robinson and Becker 1986b). On the 
first and last test day, the testing was videotaped for behavioral analysis. Behaviors were 
scored by observers blind to the experiment. The numbers of headbobs, forelimb 




Immediately after the last cocaine or saline treatment and testing, rats were 
anesthetized with a combination of ketamine (45mg/kg, i.p.) and medetomidine 
(0.3mg/kg, i.p.). A guide cannulus was implanted through the skull and aimed at the 
dorsolateral striatum (from Bregma in mm: anterior, 0.2; lateral, 3.2; ventral, 1) using 
stereotaxic procedures. Dental acrylic and jeweler’s screws were used to hold the 
cannulus on each skull.  
 
Microdialysis testing 
Microdialysis testings were conducted 9 to 14 days after the last injection of cocaine 
or saline. Microdialysis probes (CMA/11, CMA/Microdialysis AB, Chelmsford, MA, 
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USA) were tested for recovery in vitro at 37°C prior to the experiment, as described by 
Becker (Becker and Rudick 1999). On the day prior to dialysis, microdialysis probes (4 
mm dialysis membrane) were inserted into the dorsolateral striatum under 
methoxyflurane anesthesia. A Ringer’s solution (145 mM NaCl2, 2.7 mM KCl, 1.2 mM 
CaCl2, 1.0 mM MgCl2, 0.25 mM ascorbic acid; pH = 7.3) was perfused through the probe 
overnight at a rate of 0.3 µl/min. On the day of testing, the Ringer’s was pumped through 
the probes at the flow rate of 1.5µl/min using a Harvard Apparatus pump (Holliston, MA). 
Samples were collected at 10-minute intervals. Three baseline samples were collected 
before the administration of 0.1 ml oil vehicle (s. c.) followed by an additional three 
samples. Then a challenge dose of AMPH (i.p.) was administered (2.5 mg/kg for male 
rats and 2.0 mg/kg for female rats). Different doses of AMPH were used to overcome 
gender differences in AMPH metabolism. Dialysate samples continued to be collected up 
to 1.5 hour. The concentration of DA in dialysate was determined using high performance 
liquid chromatography and electrochemical detection as described previously (Becker 
and Rudick 1999). The rats’ behavior was videotaped, and the numbers of headbobs, 
forelimb movements, rearings, and quadrant crossings were counted for 10 seconds every 
five minutes. 
At the end of microdialysis testing, animals were anaesthetized with sodium 
pentobarbital and perfused with 0.9% saline followed by 4% paraformaldehyde. The 
brains were removed and the brain sections were stained with cresyl violet. The 
placement of the probes was examined under the microscopy and any animals with 




Data were subjected to analysis of variance (ANOVA) and Student’s t test. 
Differences were considered significant if p < 0.05. All data were analyzed using SPSS 
11.5 for PC.  
 
3. Results 
Cocaine-induced locomotor and stereotyped behavior during sensitization 
For saline-pretreated rats, saline-induced headbobs, forelimb movements, rearing, 
and quadrant crossing upon either the 1st or 15th injection (last) did not differ among 
CAST males, OVX females, OVXE females. Saline-induced behavior upon 1st and 15th 
injection of saline were compared and no group show behavioral habituation or 
sensitization (data not shown).  
For cocaine-pretreated rats, one-way ANOVA test indicated that CAST male, OVX 
female, OVXE female did not show any differences in headbobs (F(2,12)=1.304, 
p=0.307), forelimb movements (F(2,12)=0.626, p=0.551), rearings (F(2,12)=3.075, 
p=0.084), or quadrant crossings (F(2,12)=0.951, p=0.132), upon the 1st injection of 
cocaine (Figure 4.1-A).  
Cocaine-induced behavior upon the l5th injection of cocaine minus the 1st injection 
of cocaine was calculated to assess sensitization or habituation due to repeated cocaine 
injections (Figure 4.1-B). One sample t-test showed that only the OVXE female group 
exhibited sensitized stereotypy as total number of headbobs and forelimbs movements 
were significantly different from 0 (t (6) =2.640, p=0.039). OVX females and CAST 
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males did not show sensitization or habituation. When CAST males, OVX females and 
OVXE females were compared by one-way ANOVA, there was a significant effect of sex 
(OVX females and OVXE females didn’t differ in any behavior) as male and females 
differed significantly in sensitized headbobs (F(1,13)=8.638, p=0.012) and forelimb 
movements (F(1, 13)= 4.588, p=0.05). LSD post hoc analysis indicates significant 
difference between CAST male and OVXE female (headbobs p=0.010, forelimb 
movements p=0.035). 
AMPH-induced behavior on challenge day (day of microdialysis) 
Total number of headbobs, forelimb movement, rearing and quadrant over 30 mins 
after AMPH injections (2.5 mg/kg for male and 2.0 mg/kg for female) for saline- or 
cocaine-pretreated CAST males, OVX females, OVXE females on challenge day, during 
microdialysis, are shown in Figure 4.2.  
One-way ANOVA indicated that saline-pretreated CAST males, OVX females and 
OVXE females did not differ in their behavioral response to acute AMPH injection on the 
challenge day. The cocaine-pretreated three groups, however, exhibited different amount 
of headbobs (F (2, 14) = 4.917, p=0.024) and rearings (F(2,14)=6.197, p=0.012) in 
response to AMPH. LSD post hoc analysis indicated that OVXE female rats exhibited 
fewer headbobs than both CAST males (p=0.05) and OVX females (p=0.012), but more 





Figure 4.1: Behavior (Mean + SEM) induced by 20 mg/kg cocaine with repeated 
treatment of cocaine. A. CAST male, OVX female, OVXE female did not differ 
on cocaine-induced headbobs, forelimb movements, rearings and quadrant 
crossings upon the 1st injection of cocaine. B. Cocaine-induced behavior upon 
the l5th injection of cocaine minus the 1st injection of cocaine was calculated to 
assess sensitization or habituation due to repeated cocaine injections. The * 
indicates changes of stereotypy (total of headbobs and forelimb movements) in 
OVXE group was significantly greater than 0. The # indicates significant 
difference between OVXE females and CAST males. HB: headbobs; FM: 
forelimb movements; RE: rearing; QC: quadrant crossing. 
 
When the behavior of cocaine and saline treated groups are compared by Students’ t 
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tests, the cocaine-pretreated CAST male rats exhibited greater stereotypy as indicated by 
more headbobs (p=0.011) and forelimb movements (p=0.003) in response to AMPH 
compared to saline-pretreated rats. Cocaine-pretreated OVX female rats also showed 
greater stereotypy than did controls as indicated by more headbobs (p=0.038) in response 
to AMPH. In addition, they exhibited less rearings (p=0.037) compared to saline-
pretreated rats. Interestingly, cocaine-pretreated OVXE rats were not different from 





Figure 4.2: Behavior induced by AMPH injections on challenge day. The * indicated 
significant difference compared to paired saline rats. The # indicated different 
amount of headbobs compared to both CAST males and OVX females. The ## 
indicated significant different amount of rearings compared to CAST males.  
 
AMPH-induced changes of extracellular DA in dorsal striatum 
Two-way ANOVA indicated that CAST male, OVX female and OVXE female had 
different basal extracellular DA levels (F (2, 28) = 6.73, p=0.004) as CAST male rats had 





Table 4.2: Basal extracellular DA in the dorsal striatum (pg/μl) 
 CAST males OVX females OVXE female 
Saline-pretreated 3.2 (0.453) * 2.09 (0.37) 1.40 (0.343) 
Cocaine-pretreated 3.03 (0.453) * 2.17 (0.406) 1.91 (0.321) 
The data was expressed as Mean (SEM). * indicated different basal DA between Males 
and Females. 
 
There was no effect of cocaine pretreatment on basal DA, thus DA in striatum is 
expressed as the percent of baseline for each rat. AMPH-induced DA in dialysate from 
cocaine- or saline-pretreated CAST males, OVX female and OVXE females are shown in 
Figure 4.3. Repeated ANOVA was used to compare the six samples after AMPH 
injections between paired cocaine- and saline-pretreated groups. It indicated that cocaine- 
pretreated CAST males had significantly greater DA increase in dialysate than did saline-
pretreated controls (F (1, 6) =7.082, p=0.037). Cocaine-pretreated OVX females and 
OVXE females, however, did not show enhanced DA in dialysate compare to equivalent 







Figure 4.3: AMPH-induced DA in dialysate from cocaine- and saline- pretreated 
CAST males, OVX females and OVXE females. The * indicated significant 
difference between cocaine- and saline- pretreated CAST males.  
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Relation of AMPH-induced DA peak with behavior 
For male rats, the AMPH-induced DA peak correlated with the number of AMPH-
induced forelimb movements as shown in Figure 4.4. This relationship was not seen in 
female rats.  
 
Figure 4.4: For male rats (including cocaine- and saline-pretreated animals), 
Pearson correlation test indicates that AMPH-induced DA peak significantly 




In this experiment, repeated cocaine treatment resulted in sexually dimorphic 
patterns of both the behavioral response and the AMPH-induced increase in DA in 
dialysate from striatum. Specifically, estradiol-treated OVX female rats exhibited greater 
behavioral sensitization to cocaine during the sensitization period, than did CAST male 
rats as was predicted. On challenge day, however, repeated cocaine resulted in an 
enhanced behavioral response to AMPH, and enhanced AMPH-induced DA in dialysate 
only in CAST male rats. In females, repeated cocaine resulted in very limited behavioral 
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cross-sensitization to AMPH, and no enhanced AMPH-induced DA in dialysate.  
It has been known that OVX female rats show greater behavioral sensitization 
compared to CAST male rats and this sensitization is further enhanced by estradiol 
treatment in female rats (Becker et al. 2001; Hu and Becker 2003). We saw a similar 
pattern in this study. Female rats, especially EB-treated female rats, showed greater 
sensitization of stereotypy (headbobs and forelimb movements) compared to CAST male 
rats. More specifically, the estradiol-treated OVX group is the only group that exhibited 
sensitized stereotypy in this study, when the behavioral sensitization was assessed by 
difference between behavior induced by the 1st and the 15th cocaine injections. CAST 
male rats even show a trend of decreased stereotypy, though not at a significant level. 
Rats exhibit big individual differences in susceptibility to cocaine sensitization (Flagel et 
al. 2008). Moreover, the sample size is relatively small in this study. It is possible that we 
had a population of rats that had greater resistence to sensitization so that sensitization 
was not detected as a whole. Moreover, cocaine-induced behavior was videotaped and 
was counted by an observer in this study. It is also possible that the headbobs and 
forelimb movements counting were not the most sensitive measurement to detect changes 
of stereotypy at the dose of 20 mg/kg cocaine. Nonetheless, females exhibited greater 
behavioral sensitization to cocaine than males in this study as predicted. 
Surprisingly, we found the opposite pattern on AMPH-induced behavioral responses 
on challenge day. Cocaine-pretreated CAST males showed cross sensitization to AMPH 
as they exhibited twice the number of headbobs and three times the number of forelimb 
movements exhibited by saline-pretreated rats. Compared to male rats, OVX female rats 
showed very limited cross sensitization to AMPH as they only exhibited 30% more 
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headbobs compared to saline-paired group. Lastly, OVXE rats did not show any 
behavioral cross sensitization to AMPH even though they showed the most robust 
sensitization to cocaine during repeated cocaine treatment.  
Cross-sensitization between AMPH and cocaine has been demonstrated in several 
paradigms. Repeated systemic AMPH administrations are known to produce sensitized 
locomotor activation to cocaine (Bonate et al. 1997; Schenk et al. 1991; Shuster et al. 
1977), and a sensitized reinforcing effect to cocaine as assessed by cocaine self-
administration (Horger et al. 1992; Valadez and Schenk 1994). Direct AMPH exposure in 
VTA also enhances cocaine self-administration under progressive ratio procedures (Suto 
et al. 2002; Suto et al. 2003). The above studies, however, have all focused on the ability 
of repeated AMPH to produce cross-sensitization with the effects of cocaine. There are 
very few studies addressing the ability of repeated cocaine to produce cross-sensitization 
with the effects of AMPH. A very early study has demonstrated that cocaine does not 
necessarily produce cross- sensitization to AMPH when vice versa is true (Shuster et al. 
1977). Similarly, cross-sensitization to AMPH produced by morphine did not guarantee 
that AMPH could produce cross-sensitization to morphine either (Vanderschuren et al. 
1999c). Thus, we need to be very careful when we consider the ability of cocaine to 
produce cross-sensitization to AMPH.  
Our observation is consistent with a previous study showing that cocaine-pretreated 
male rats show cross-sensitization to AMPH (Pierce and Kalivas 1995). Cocaine 
exposure has also been demonstrated to produce sensitized rewarding effect of AMPH 
(Liu et al. 2007). Even though cross-sensitization has not been examined in females in 
vivo, in vitro superfusion experiments suggest cocaine sensitization results in enhanced 
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striatal DA neuron reactivity to AMPH in both males and females (Peris et al. 1990; Peris 
et al. 1991). Thus, it is not likely that female rats did not develop cross sensitization to 
AMPH at all.  
It is known that drug administration environment powerfully modulates both the 
development and expression of behavioral sensitization (Badiani and Robinson 2004; 
Robinson et al. 1998). When a drug is repeatedly administered to rats in one environment, 
robust sensitized response is produced when the drug is subsequently administered in the 
same drug-paired environment. But sensitization may not be expressed if the drug is 
administered in a non-paired environment (Anagnostaras and Robinson 1996; Mattson et 
al. 2008). Cross-sensitization between AMPH and cocaine has been shown to be context-
dependent as well (Bonate et al. 1997). In this study, all animals were challenged by 
AMPH in microdialysis chamber, which was a novel environment for them. The 
observation that female rats, but not male rats, failed to express cross-sensitization to 
AMPH in novel environment may suggest greater vulnerability to the influence of 
context in females. But van Haaren’s observation, that intact female rats develop 
sensitization to AMPH in home cages while males fail to do so, suggest that females may 
be more insensitive to the environment (van Haaren and Meyer 1991). This difference 
between males and females in van Harren’s study, however, may also due to different 
metabolism rate of AMPH as the effect of context on sensitization also depends on drug 
doses and time of context exposure (Todtenkopf and Carlezon 2006). I am not aware of 
any other studies looking at the effect of context on the expression of cocaine 
sensitization in female rats. Thus this hypothesis still remains open for further 
investigation. Nonetheless, if the above hypothesis is correct, it may contribute to clinical 
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observation that better treatment outcome is observed in cocaine dependent women 
compared to cocaine-dependent men (Kosten 1993; Weiss et al. 1997). 
Another possibility is the sex differences in the stress system. In males a novel 
environment activates the stress axis and enhances sensitization and drug taking (Piazza 
and Le Moal 1998; Sorg and Kalivas 1991). The effect of stress on drug related response 
is suggested to be mediated by circulating glucocorticoids. Evidence suggests that an 
optimal level of glucocorticoids is necessary for favoring drug taking. If the levels of 
circulating glucocorticoids exceed this optimal range, it may decrease drug taking 
(Goeders and Guerin 1996; Kabbaj et al. 2001). It is known that there are greater stress 
responses, that include greater hypothalamic-pituitary-adrenal (HPA) axis activation and 
higher glucocorticoids level following stress, in females than males (Gozen et al. 2007; 
Mitsushima et al. 2003; Wilson and Biscardi 1994). It is possible that greater stress 
response induced by the novel environment in females has already exceeded the optimal 
stress ranges, thus compromised or inhibited behavioral response to drug. This would 
explain why the female rats sensitized in the home cage and then didn’t show 
sensitization when challenged in a novel testing chamber.  
Consistent with previous reports (Becker and Ramirez 1981b; Castner et al. 1993; 
Xiao and Becker 1994), nigrostriatal DA system is sexually dimorphic as males had 
higher extracellular DA than females. Similar to different behavioral response to AMPH, 
we saw different neurochemical response to AMPH as well. In male rats, cocaine-
pretreated rats show enhanced AMPH-induced release of DA in striatum. And more 
importantly, the DA peak in male rats is correlated with forelimb movements in male rats, 
which is consistent with the notion that stereotypy is mediated by the dorsal striatum 
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(Castall et al. 1977). Similar relationship of AMPH-induced stereotypy and DA release in 
striatum has been reported before (Lienau and Kuschinsky 1997). It supports the idea that 
behavioral sensitization is associated with sensitization of presynaptic DA transmission 
(Kalivas and Stewart 1991). However, cocaine-pretreated female rats fail to show 
sensitized DA activity in response to AMPH, which is parallel with very limited 
expression of behavioral sensitization. Thus, it is very likely that diminished DA response 
is due to the same reason I mentioned above causing diminished behavioral response. 
Neural mechanisms mediating the effect of context or stress may directly or indirectly 
influence DA neuron reactivity. (Gozen et al. 2007; Klebaur et al. 2002; Mattson et al. 
2008; Uslaner et al. 2001a; Uslaner et al. 2001b).  
Another thing that should be kept in mind is the relationship between DA 
transmission and behavioral sensitization to cocaine has always been inconsistent 
(Heidbreder et al. 1996; Hooks et al. 1994; Kalivas and Duffy 1990; 1993; Meil et al. 
1995; Segal and Kuczenski 1992b). Studies reporting a sensitization of DA transmission 
to cocaine utilized an interval of more than 14 days (Hooks et al. 1994; Kalivas and 
Duffy 1993) while those who failed to observe it utilized an interval of 10 days or less. It 
was hypothesized that enhanced DA release in NAc and striatum is developed after long 
withdrawal from chronic psychostimulants administration (Kalivas and Duffy 1993). 
Peris’s studies suggest the more treatments were given, the longer withdrawal it requires 
to develop DA sensitization (Peris et al. 1990; Peris and Zahniser 1987; 1989). It is 
possible that females need shorter or longer withdrawal to develop DA sensitization 
compared to males. Further experiment with different withdrawal in females is needed to 
test this hypothesis.  
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DA sensitization associated with cocaine treatment has also been shown to be dose- 
and subregion-dependent (Cadoni and Di Chiara 1999). When cocaine pretreatment 
results in behavioral sensitization to both low and high dose of cocaine challenge, 
sensitized DA transmission is only observed to the lower dose of cocaine challenge in the 
NAc core while a reduction of DA response was observed after the higher dose in the 
shell region. Clinical studies also found that AMPH-induced DA release was decreased in 
striatum in cocaine-dependent subjects as assessed by PET scan (Martinez et al. 2007). It 
suggests that the reactivity of striatal DA neuron may exhibit a reversed U shape in 
response to psychostimulants or could be impaired by high dose of psychostimulants. 
Thus, it is possible that the regimen of high dose of cocaine treatments and high dose of 
AMPH challenge was too aggressive for females that it leads to the ceiling effect or 
attenuated DA response.  
Taken together, the current study suggests that males and females exhibit sexually 
dimorphic patterns of behavioral sensitization to repeated treatments of cocaine and in 
response to AMPH challenge. Females, though exhibit greater behavioral sensitization to 
cocaine than do males, but do not show cross-sensitization between cocaine and AMPH 
to the same extent as do males. This sex difference in sensitization may be related to 
sexually dimorphic pattern of DA neuron activity in striatum. Understanding the 
underlying neural mechanisms associated with long term use of psychostimulants in both 
males and females is critical to understand sex difference in cocaine abuse and develop 








CONCLUSIONS AND FUTURE DIRECTION 
1. Summary of findings and working hypothesis 
The patterns of cocaine use have been found to differ between men and women 
(Wetherington 2007). Both clinical and preclinical studies suggest sex differences in 
response to cocaine are mediated by both intrinsic sex differences and ovarian hormones. 
This dissertation was designed to further characterize the underlying mechanisms 
mediating sex differences in responses to cocaine, in particular the response to repeated 
cocaine treatment. The questions that have been addressed in the preceding chapters are: 
1) how does estradiol treatment affect behavioral sensitization to cocaine? Does estradiol 
produce an acute activating effect on sensitized neural circuits? Does estradiol influence 
the neural processes involved in sensitization to repeated cocaine treatment? Or both? 2) 
How do previous repeated cocaine treatments and estradiol influence acquisition of 
cocaine self-administration? Is this cocaine experience associated with enhanced 
dopamine (DA) transmission in nucleus accumbens (NAc) and striatum in vitro in 
females? 3) Are sex differences in cocaine sensitization associated with a corresponding 
sexually dimorphic pattern of DA sensitization in the striatum in vivo?  
The experiments described in Chapter II was the first experiment trying to 
understand how estradiol influence cocaine sensitization, either through activational 
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effect on sensitized brain or influence neural processes associated with sensitization or 
both. For the first time, it was found that acute estradiol on challenge day enhanced 
behavioral activation in cocaine-sensitized rats. This result suggests that estradiol 
produces an independent acute activating effect on sensitized neural circuits to affect 
behavioral sensitization. Estradiol, given with repeated cocaine treatment, enhanced 
cocaine-induced behavioral activation post sensitization on challenge day after 
withdrawal from cocaine and estradiol, suggesting estradiol may also directly influence 
neural sensitization occurring with repeated cocaine treatment.  
Sensitization is thought to be a process associated with an enhancement of the 
reinforcing effect of drugs. This hypothesis has been proposed largely based on 
preclinical studies on males. Experiment in Chapter III, for the first time, found that prior 
cocaine exposure, which was much more powerful than estradiol, promoted the 
acquisition of cocaine self-administration and cocaine taking in females, suggesting the 
same hypothesis is applicable to females as well. Moreover, it was the first experiment 
showing that chronic cocaine experience was associated with enhanced DA transmission 
in NAc as well as in striatum in vitro.  
Even though DA system was found to be sensitized in females as in males after 
cocaine exposure in vitro, this hypothesis has not been tested in vivo in females yet. 
Chapter IV directly compared male and females in one experiment to test the hypothesis 
that sex differences in cocaine sensitization are associated with sexual dimorphic pattern 
in DA sensitization with repeated cocaine treatments. It was found that males and females 
did exhibit sexually dimorphic patterns of behavioral sensitization to repeated treatments 
of cocaine and in response to AMPH challenge. Females, though exhibited greater 
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behavioral sensitization to cocaine than did males, but did not show cross-sensitization to 
AMPH on challenge day while undergoing microdialysis, while males did. More 
importantly, the DA system in response to AMPH challenge in vivo after cocaine 
sensitization was also sexually dimorphic, which is consistent with the hypothesis that 
sex differences in cocaine sensitization are associated with a sexually dimorphic pattern 
of DA sensitization. 
 
2. Mechanisms mediating sex differences in the effects of cocaine 
 
Based on current knowledge, the following model is presented to explain some 
mechanisms mediating sex differences in cocaine abuse. First of all, cocaine produces 
psychomotor stimulating and reinforcing effects through its activation of the ascending 
midbrain DA system, in particular by enhancing extracellular DA levels in NAc and 
striatum. Repeated DA activation associated with repeated cocaine treatment first initiates 
some transient neuroadaptations in cell body regions (VTA and SNc), such as 
subsensitivity of autoreceptors that may contribute to an enhanced basal activity of DA 
neurons and transient increase in basal DA transmission in DA terminal regions. These 
transient responses might be important for initiating more persistent changes in DA 
terminal areas (NAc, striatum and prefrontal cortex), including enhanced 
psychostimulants-induced DA release, D1 receptors supersensitivity and upregulated D2- 
high receptors. The enhanced DA transmission in terminal area may be responsible for 
the expression of behavioral sensitization and enhanced reinforcing effect of 
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psychostimulants resulted from repeated cocaine exposure (Figure 5.1).  
Related to sex differences in the acute response to cocaine, the ascending midbrain 
DA system, in particular the striatum and NAc, is sexually dimorphic. The sex 
differences in acute response to cocaine are probably mediated directly by striatum and 
NAc. In particular, independent of gonadal hormones, castrated (CAST) males have 
higher basal DA level in striatum than ovariectomized (OVX) females (Castner et al. 
1993). If DA levels in striatum and NAc critically determine psychomotor stimulant and 
reinforcing effect of cocaine, the sex differences in basal DA tone of the striatum and 
NAc may have determined a different amount of DA that is required to induce behavioral 
activation or reinforcing effect in males vs. females (more DA may be required for males). 
Thus, with same amount of cocaine stimulation, females are more likely to show greater 
behavioral activation and feel greater subjective reinforcing effect of cocaine than are 
males. In addition, one acute effect of estradiol in the striatum and NAc is to directly 
enhance psychostimulants-induced DA release. This acute effect probably happens 
through an activation on estrogen receptors located on the extracellular membrane of 
medium spiny striatal neurons to reduce calcium current and results in a decreased 
GABA release, which then disinhibits DA neuron terminals to enhance stimulated striatal 
DA release (Becker 1999; Becker and Hu 2008). Thus, DA mediated postsynaptic 
transmission are further enhanced in estradiol-treated females (Figure 5.2).  
The reason that an acute effect of estradiol on the acute behavioral response to 
cocaine is not usually seen is this enhanced DA output is not strong enough to result in 
behavioral effect. After repeated cocaine treatment, psychostimulants-induced DA 
transmission in striatum and NAc is enhanced. Thus, estradiol directly works on 
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sensitized DA terminals in striatum and NAc to further enhance cocaine-stimulated DA 
increase and results in enhance behavioral output after cocaine sensitization. This is 
probably one of the mechanisms contributing to the enhancing effect of estradiol on 
cocaine sensitization. 
In addition to the acute effect of estradiol, chronic estradiol treatment also results in 
neural functional changes on striatum and NAc that require longer time to occur. Chronic 
estradiol treatment results in increased DA D2 receptor sensitivity and density (Hruska 
and Silbergeld 1980; Lammers et al. 1999; Landry et al. 2002; Zhou et al. 2002), 
increased DA uptake site density (Morissette and Di Paolo 1993a), increased turnover of 
DA in NAc (Shimizu and Bray 1993), decreased expression of DAT in striatal astroglia 
cultures (Karakaya et al. 2007), and modified G-protein coupling process stimulated by 
D1 and D2 DA receptor agonist (Maus et al. 1989a; Maus et al. 1989b). Thus, as a result 
of progressively prolonged estradiol exposure with repeated estradiol treatment, estradiol 
may also enhance behavioral effects of cocaine at the later stage of sensitization through 
some of the above mechanisms. This may also contribute to enhanced behavioral 
sensitization in estradiol-treated females.   
    Until now, there is no direct evidence showing that the effect of estradiol on the 
straitum or NAc (either acute or long term effect I mentioned above) would interact with 
the neural adaptitive changes produced by repeated cocaine treatment. Even though 
estradiol didn’t significantly interact with cocaine treatment to influence cocaine-induced 
behavior on challenge day, estradiol treatment did enhance cocaine-induced behavioral 
activation only in cocaine-pretreated rats (Chapter II). Similar observation has been 
reported by another study (Hu and Becker 2003). Moreover, cocaine-pretreated OVX 
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females exhibited some sensitized stereotypy (headbobs) in response to AMPH challenge 
while OVX females that received estradiol treatment with repeated cocaine treatment did 
not exhibit any cross-sensitization to AMPH at all on challenge day (no estradiol 
treatment on challenge day, Chapter IV). Taken together, those behavior data suggest that 
estradiol may also interact with repeated cocaine treatment to influences the neural 
adaptations associated with cocaine sensitization. 
Additionally, a very recent electrophysiological study demonstrated that both basal 
and cocaine-induced activity of VTA DA neurons fluctuates significantly during the 
estrous cycle, and was also modulated by systemic estradiol treatment (Zhang et al. 2008). 
This fluctuation of VTA neuron activity is in agreement with the fluctuation of DA 
concentration in medial prefrontal cortex measured by microdialysis during the estrous 
cycle (Dazzi et al. 2007). Even though ERβ is present in VTA (Creutz and Kritzer 2002; 
Shughrue et al. 1997; Shughrue and Merchenthaler 2001), there is no evidence showing a 
direct effect of estradiol on VTA. Thus, this regulation of VTA DA activity by estradiol 
could be mediated by a direct effect of estradiol on VTA or an indirect influence of 
estradiol on striatum and NAc, or both. Nonetheless, the regulation of VTA DA neuron by 
estradiol, and a critical role of VTA in initiating sensitization, present a possibility that 
estradiol may influence some neural events occurred with cocaine sensitization. 
Taken together, repeated cocaine treatment produces persistently enhanced DA 
transmission in NAc and striatum to enhance the behavioral and reinforcing effects of 
cocaine. Estradiol, to a lesser extent, produces an independent action on DA transmission 
in striatum and nucleus accumben to enhance behavioral and reinforcing effects of 
cocaine. These two processes, though occur independently, but work together and result 
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in greater behavioral sensitization in estradiol-treated female rats than in OVX female 
rats. Further experiments are needed to verify if estradiol influence the neural process 
















Figure 5.2 Sex differences in basal and cocaine stimulated-DA increase in DA 
terminal areas (NAc and striatum) determine the sex differences in 
psychostimulant and reinforcing effects of acute cocaine administration. 
 
Even though a large body of preclinical and clinical studies suggests that 
dopaminergic neurotransmission is critical in mediating the reinforcing effects of cocaine 
in humans. The intriguing thing is treatment based on antidopaminergic mechanism fails 
to show an effect at treating cocaine dependence (Sherer et al. 1989). Thus the role of DA 
in cocaine abuse needs to be carefully examined. The hallmark of cocaine addiction, 
distinguished from casual cocaine use, is compulsive drug abuse despite negative 
consequence, and high rates of relapse during periods of abstinence (Dackis and O'Brien 
2001; Mendelson and Mello 1996). Recently, a critical role of glutamate projections from 
medial prefrontal cortex (mPFC) to VTA and NAc in cocaine sensitization has been 
recognized (Kalivas 2004; Kalivas et al. 2003; Wolf 1998) and is found to mediate 
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relapse to cocaine-seeking behavior (Kalivas and McFarland 2003; Kalivas et al. 2003). 
Pathology of glutamate transmission from prefrontal cortex to NAc after sensitization has 
also been hypothesized to account for impulsive drug abuse in addiction (Kalivas et al. 
2005).  
Therefore, DA may be mediating the reinforcing effect of cocaine and be important 
for maintaining initial use of cocaine. With repeated cocaine treatment, DA transmission 
in DA terminal areas is enhanced, which is responsible for behavioral sensitization and 
enhanced reinforcing effect of psychostimulants. More importantly, the persistent DA 
release might be important for initiating a series of neural events to progressively recruit 
glutamatergic system and associated limbic brain regions and the prefrontal cortex, so 
that gluatamate neurons start to show dramatic response to cocaine and related stimuli, 
which contribute to compulsive drug abuse in addiction (Kalivas et al. 2005).  
Thus, if the acending midbrain mesolimbic DA system, which mediate the primary 
behavioral and subjective effect of cocaine, is sexually dimorphic and is modulated by 
estradiol in females, it is very likely that there are sex differences in DA-initiated neural 
events with repeated cocaine use, that lead to a sex difference in glutamate transmission 
in NAc, cortical area and other related limbic structure. This may contribute to a sex 
difference in the transition from casual cocaine use to compulsive cocaine abuse as well 
as sex differences in relapse. Until now, the knowledge of the role of glutamate on 
cocaine sensitization in females is very poor. Thus, looking at the interaction of the DA 
and glutamate systems in the process of cocaine sensitization in females and 
understanding its role for compulsive cocaine taking and relapse is an important step for 






Effect of progesterone on behavioral sensitization to cocaine in 
female rats 
1. Introduction 
    Cocaine is one of the most widely abused drugs in western countries. Cocaine abuse, 
particularly by women, has increased in the last decade. According to the 1998 National 
Household Survey on Drug Abuse, currently among the 1.8 million Americans who use 
cocaine, approximately 36% are female (NHSDA, 1998). Thus, cocaine dependence in 
women is a growing public health concern. A great portion of women who try cocaine 
develop lifetime dependence upon cocaine (Kandel et al. 1995) Clinical studies suggest 
that women show a different pattern of cocaine abuse than do men. Women begin using 
cocaine and enter treatment at earlier ages than men (Griffin et al. 1989). After being 
addicted, cocaine cues induce more drug craving in female than male addicts (Robbins et 
al. 1999). In addition, women report less pleasure and dysphoria, and greater anxiety in 
response to cocaine than men (Kosten et al. 1996; Lukas et al. 1996; Singha et al. 2000). 
Collectively, these data suggest that women may be more vulnerable to the addictive 
effect of cocaine than men.  
     Repeated exposure to psychomotor stimulants, such as cocaine, results in enhanced 
behavioral responses to subsequent drug treatment in humans and laboratory animals. 
This is called behavioral sensitization (Robinson and Berridge 2003). It is suggested that 
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sensitization-related neuroadaptations play an important role in the processes of drug 
addiction (Robinson and Berridge 1993; 2000b; Wyvell and Berridge 2001). Thus, 
behavioral sensitization is often used to explore the mechanism underlying drug addiction 
in animal models.  
Preclinical studies on rodents indicate that there are differences between the 
biological sexes. Female rats displayed greater cocaine induced stereotypy and locomotor 
activity than males (Festa et al. 2004; Sell et al. 2000). They acquired self-administration 
of cocaine at a faster rate than male rats, and a greater percentage of females acquired 
cocaine self-administration (Lynch and Carroll 1999). Moreover, female rats showed 
more robust sensitization to cocaine than males (Cailhol and Mormede 1999). The fact 
that brain concentrations of cocaine after systemic administration are comparable for 
male and female rats promotes us to explore mechanism other than cocaine 
pharmacokinetics (Bowman et al. 1999).  
Some evidence suggests that intrinsic sex differences in brain organization during 
development may partially account for sex differences in responses to psychomotor 
stimulants. Ovariectomized (OVX) female rats showed greater behavioral sensitization to 
cocaine and self-administer more cocaine at a faster rate than castrated (CAST) male rats 
(Hu and Becker 2003; Hu et al. 2004).  
Besides the genetic sex difference, circulating gonadal hormones are also thought to 
play a role in modulating vulnerability to drug use in females since the response to 
cocaine differs across the estrous cycle in females (Becker 1990a; b; 1999; 2000; Kippin 
et al. 2005; Lynch et al. 2000). For example, hyperactivity induced by cocaine was 
greatest in female rats during proestrus and estrus (Sell et al. 2000). Female rats 
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responding for cocaine under a progressive ratio schedule also reach a higher breaking 
point during estrus than during other phases of the estrous cycle (Roberts et al. 1989).  
Further studies identified estradiol as a key factor modulating cocaine-induced 
response. It is known to facilitate behavioral responses, including cocaine-induced 
locomotor and stereotyped activity, self-administration of cocaine as well as cocaine-
induced behavioral sensitization, to either acute or repeated injection of cocaine in 
females (Hu and Becker 2003; Lynch et al. 2001; Sell et al. 2000).  
    Progesterone is another major hormone, besides estradiol, fluctuating over the 
menstrual cycle in women. Clinical reports showed that women have a greater subjective 
response to both cocaine (Evans et al. 2002; Sofuoglu et al. 1999) and AMPH (Justice 
and de Wit 1999; White et al. 2002) in the follicular phase of the menstrual cycle, when 
estradiol is predominant, as compared to the luteal phase, when both estradiol and 
progesterone are elevated. Since the luteal phase is characterized by higher progesterone 
levels than the follicular phase is, progesterone is implicated as an agent that may 
attenuate the cocaine response in women. These results were consistent with preclinical 
studies that examined progesterone and cocaine interactions. Two recent studies indicate 
that progesterone treatment blocked the conditioned place preference for cocaine in mice 
(Russo et al. 2003b) and rats (Russo et al. 2003a). Administration of estradiol and 
progesterone suppressed cocaine-induced locomotion when compared to estradiol treated 
animals (Quinones-Jenab et al. 2000). A recent study conducted by (Jackson et al. 2006) 
also demonstrated that concurrent administration of progesterone with estradiol 
ameliorates the enhancement effect of estradiol in cocaine self-administration. Contrary 
to that, acute administration of progesterone was shown to enhance cocaine-induced 
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locomotor activity in estradiol primed OVX rats (Perrotti et al. 2001). At the same time, 
OVX rats implanted with silastic capsules containing both estradiol and progesterone 
showed greater magnitude of cocaine conditioned place preference (Russo et al. 2003a). 
It is possible that progesterone plays a role in the facilitation or inhibition of estradiol’s 
effect on cocaine-induced behavior. Due to these conflicting data, the effect of 
progesterone still remains to be determined. Thus, the goal of present study is to 
determine the effect of progesterone on behavioral sensitization to cocaine in female rats 
and seeks to determine how progesterone and estradiol interact to modulate the 
behavioral response to cocaine. 
 
2. Materials and Methods 
Animals 
Female Sprague Dawley rats (Harlan Inc, Indianapolis, IN), weighing 225-250 gm at 
the start of the experiment, were housed two to three per cage under a 14/10 hr light/dark 
cycle. Animals were housed in a room maintained at a constant temperature of 20-21℃ 
with phytoestrogen-free rodent chow (2014 Teklad Global Harlan rat chow; Harlan 
Teklad, Madison, WI) and water available ad libitum. All procedures were performed 
according to a protocol approved by the University of Michigan Committee for Use and 
Care of Animals.  
Surgery 
Approximately one week after arrival, animals received 6-hydroxyDA (6-OHDA) 
lesions of the nigrostriatal DA pathway. Animals were given pargyline (35 mg/kg, i.p.) to 
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inhibit 6-OHDA metabolism, desipramine (15 mg/kg, i.p) to protect noradrenergic cells at 
least half hour before 6-OHDA infusion. They were anesthetized with ketamine (40 
mg/kg) and domitor (medetomidine hydrochloride, 0.3 mg/kg). Lesion coordinates 
measured from bregma, skull flat, were as follows: posterior, 5.0 mm; lateral, 2.0 mm; 
and ventral, 7.7 mm. A solution of 8.26 μg of 6-OHDA hydrobromide (2 μg/μl in 0.1 
mg/ml L-ascorbic acid in 0.9% sterile saline) was infused into the substantia nigra 
through a 29 gauge cannula at a rate of 0.5 μl/min for 8.25 min (for a total infusion of 
4.13 μl). The infusion cannula was left in place for 2 min before being slowly raised to 
allow the infusion to disperse. 
Two weeks later, all rats underwent a test with apormophine because apomorphine-
induced rotation can be used to predict lesions of the striatum over 90% (Hudson et al. 
1993). Each rat was placed into the rotometer for habituation and rotational behavior was 
recorded from the beginning of habituation. After 30 min, each rat was injected 
intraperitoneally with apomorphine (25 mg/kg) and then tested for 1 hr. Satisfactory 
performance were defined as having over 100 full turn per hour and >95% of them were 
the turn to the side contralateral to the lesion side. 
Only the rats that passed the apormorphine test underwent the following surgery. 
The rats underwent gonadectomy or sham surgery under isoflurane anesthesia. 
Ovariectomy is conducted using a dorsal approach. The skin is opened with an incision 
～1 cm long along the midline just below the ribs, and a small incision (～0.5 cm) is 
made through the muscle ～1.5-2 cm lateral to the midline. The ovary is externalized 
with blunt forceps, and the tissue between the ovary and uterus is clamped with a 
hemostat. The ovary is removed, and the hemostat remains in place until there is no 
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bleeding when it is released. The uterus with associated tissue is returned to the abdomen. 
The procedure is repeated on the other side, and wound closure is via 11 mm wound clips. 
After 4 d of recovery, all female rats underwent vaginal lavage testing daily for 10 
consecutive days to confirm cessation of cycling. 
Rotational behavior 
Subjects were assigned to one of five groups: (1) Ovariectomized (OVX) females 
treated with 0.2 ml of peanut oil vehicle; (2) OVX females treated with 5μg of 17β-
estradiol in 0.1ml of peanut oil (OVX+E) and 0.1ml of peanut oil; (3) OVX females 
treated with 125 μg of progesterone in 0.1 ml of peanut oil (OVX + P) and 0.1 ml of 
peanut oil; (4) OVX females concurrently treated with 5μg of 17β-estradiol in 0.1ml of 
peanut oil and 125 μg of progesterone in 0.1 ml of peanut oil (CPE) (5) OVX rats 
sequentially treated with 5 μg of 17β-estradiol in 0.1 ml of peanut oil and 125 μg of 
progesterone in 0.1 ml of peanut oil (estradiol for 3 days, progesterone on the 4th day, oil 
on the 5th day). Each rat was placed into the rotometer for habituation for half an hour 
and then was injected subcutaneously with either hormone or vehicle. Rotational 
behavior was recorded from the beginning of habituation. 30 min after hormone/vehicle 
injection, each rat was injected intraperitoneally with either saline or 10mg/kg cocaine 
and then tested for additional 1 hr. The computer program recorded 360° rotation in 5 min 
intervals during the whole 120 min period. Numbers of animals in each group are 
included in the figure legends. Rats were tested for 5 consecutive days followed by 2 d 
off each week for 3 consecutive weeks. On each test day, animals received hormone or 
vehicle, and on the 2 d off, no hormone or cocaine was administered. 
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Striatal DA determination 
Around two weeks after testing, all rats were decapitated. Their brains were 
removed rapidly, and the striatum on each side was dissected. The two striatal samples 
were each weighed and then homogenized in 400μl of a solution containing an internal 
standard (dihydroxybenzylamine), 2 mM EDTA, and 0.1 M sodium metabisulfate 
dissolved in 0.05 N perchloric acid. These samples were then centrifuged at 3500×g, 
filtered through 0.2 μm filters, and transferred to autosampler vials for DA analysis using 
HPLC with electrochemical detection (Coulochem II, ESA, Waltham, MA), as described 
previously (Becker and Freed 1988). Percentage DA depletions were calculated by 
subtracting the concentration of DA per milligram of wet tissue weight on the lesioned 
side from the value on the intact side. This result is divided by the value on the intact side, 
providing a percentage depletion of DA. Rats whose percentage depletion was <95% and 
rats who turned in the wrong direction or who did not show a clear bias during testing 
were eliminated from the study.  
Statistical analysis 
The total number of net rotations was calculated as the sum of the number of 
contraversive rotations during the 60 min testing period minus the number of ipsiversive 
rotations for each rat. Comparisons were made by ANOVA and subsequent post hoc 
comparisons with Fisher’s PLSD test, with significance set at p ≤ 0.05 for individual 
comparisons. All data were analyzed using the computer program Statview 4.5 (Systat, 
Evanston, IL) for Macintosh (Apple Computers, Cupertino, CA) and SPSS 11.5 (SPSS, 
Chicago, IL) for Windows (Microsoft Corporation, Redmond, WA). 
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3. Results 
Acute response to cocaine 
Acute effects of the first treatment with cocaine or saline on rotational behavior are 
shown in Figure A.1. There was no significant effect of hormone on the first day of 





Figure A.1: Rotational behavior induced by first injection of cocaine or saline. There 
was no significant effect of hormone on the first day of testing either among saline 
groups or cocaine groups. 
 
Response to repeated treatment of cocaine 
In order to test the effect of sensitization, I chose day 1 as the start of sensitization. 
Compare to that, the mean of day 13, 14 and 15 may be more appropriate to represent the 
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end of sensitization because OVX+E+P group got different treatment on the last three 
days (E on 13th, P on 14th, O on 15th).  
All rats that received repeated injection of cocaine exhibited sensitization of 
rotational behavior, as defined by a progressive enhancement of rotational behavior with 
repeated drug treatment. For all cocaine groups, there was a significant interaction 
between hormone and testing days (F(4,65)= 3.136, p=0.020), main effect of testing day 
(F(1,65)=223.85, p<0.0001), main effect of hormone (F(4, 65)=3.366 p=0.014).  
Figure A.2 shows the mean + SEM number of net rotations per hour for each 
cocaine group at both the start and end of testing. Post hoc comparison showed that in the 
end of sensitization, OVX+E group rotated significantly more than OVX group (p=0.014), 
OVX+P group (p=0.017) and concurrent E+P group (p=0.006). Besides that, sequential 
E+P group also rotated significantly more than OVX group (p=0.031), OVX+P group 
(p=0.034) and concurrent E+P group (p=0.013), but not more than OVX+E group 
(p=0.072). There is no difference among OVX, OVX+P, concurrent E+P groups in the 
last three days. As we have already shown before, there is no difference among the five 
groups at the beginning of sensitization. Thus, sensitization is enhanced in OVX+E and 



































Figure A.2: Cocaine-induced rotational behavior at the start (1st day) and the end 
(mean of last three days) of sensitization. Sensitization was enhanced in OVX+E 
(n=10) and sequential E+P (n=11) groups compared to OVX (n=28), OVX+P (12), 
concurrent E+P (n=9) groups. There is no difference between OVX+E and 
sequential E+P groups, or among OVX, OVX+P and concurrent E+P groups. 
 
Response to repeated treatment of saline 
For all saline groups, there was no interaction between hormone and testing day (F(4, 
56)=1.243, p=0.303), no main effect of hormone (F(4, 56) = 0.299, p=0.877), but main effect 
of testing day (F(1, 56)=49.210, p<0.0001), as shown in Figure A.3. Thus saline groups, to 
a very limited extend, also showed behavioral sensitization. 
I divided the rats into cocaine and saline groups in order to compare their 
performance on challenge day. However, data showed that the saline groups also got 

































Figure A.3: Saline-induced rotational behavior at the start (1st day) and the end 
(mean of last three days) of sensitization. There was no interaction between 
hormone and testing day, no main effect of hormone, but main effect of testing day. 




    In the present study, we replicated earlier finding that in the OVX rats, estradiol 
enhances the behavioral sensitization to cocaine (Hu and Becker 2003). More importantly, 
we now first report that (1) concurrent administration of progesterone with estradiol 
ameliorates this effect of estradiol, (2) sequential administration of estradiol and 
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progesterone also enhances cocaine induced behavioral sensitization as estradiol, and (3) 
progesterone alone does not have any effect on behavioral sensitization to cocaine in 
female rats. Thus, progesterone can either facilitate or impede the effect of estradiol on 
behavioral sensitization to cocaine based on how they are administered. 
     The enhancement effect of estradiol on cocaine sensitization has been reported by 
Hu and Becker (Hu and Becker 2003). It is demonstrated again in this study. Actually, 
estradiol has long been known to facilitate the psychomotor activating and rewarding 
effect of psychomotor stimulant drugs (Becker 1990b; Becker et al. 1982; Carroll et al. 
2004; Hu and Becker 2003; Hu et al. 2004; Jackson et al. 2006; Lynch et al. 2000; Lynch 
et al. 2001). This effect of estradiol may be mediated by its actions on DA (DA) 
neurotransmission in striatum (Becker 1999). Female rats during estrus have a 
significantly greater basal and AMPH-induced increase in extracellular DA in striatum 
and estradiol enhances the AMPH-induced striatal DA release both in vitro and in vivo 
(Becker 1990a; b; Becker and Cha 1989; Xiao and Becker 1994). In addition, acute or 
chronic estradiol treatment increases DA turnover (Di Paolo et al. 1985), modulates DA 
receptor density and affinity as well as uptake sites (Di Paolo et al. 1988; Levesque and 
Di Paolo 1988; 1989; Morissette and Di Paolo 1993a; b).  
Consistent with past studies, our results show that s.c. estrogen administration, 
however, does not affect behavioral response to acute cocaine administration (Hu and 
Becker 2003; Quinones-Jenab et al. 2000; Sircar and Kim 1999). It is possible that 
estrogen’s effects on cocaine-induced activity varies with the route of exposure because it 
was shown that estrogen, if administered via SILASTIC capsules, potentiates cocaine-
induced behavioral effects (Perrotti et al. 2001; Sell et al. 2000).  
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    Progesterone alone was found to have no effect on behavioral response either to 
acute or repeated cocaine treatment in this study.  It is in agreement with most studies 
showing that progesterone has no effect on cocaine-induced locomotive acitivity (Perrotti 
et al. 2001; Sell et al. 2000; Sircar and Kim 1999), especially at the dose we were using 
(Niyomchai et al. 2005). However, administration of 50 and 500 μg of progesterone 24 h 
before cocaine administration inhibited rearing responses (Niyomchai et al. 2005). In 
addition, Russo et al. (Russo et al. 2003a) showed that progesterone replacement via 
SILASTIC capsules attenuated cocaine conditioned place preference (CPP). Thus, the 
effect of progesterone is also dose and route dependent. Different mechanisms might be 
involved and have yet to be determined. 
    Another important finding here is that progesterone counteracted the effect of 
estradiol on behavioral sensitization. This is not surprising because Jackson (Jackson et al. 
2006) has demonstrated that progesterone counteracted the effect of estradiol on cocaine 
self-administration. Jackson proposed three mechanisms to explain the inhibitory effect 
of progesterone on cocaine self-administration. Progesterone could counteract the effect 
of estradiol by either dimishing some subjective effect of cocaine, or by influencing DA 
system, which is assumed to mediate the reinforcing and incentive motivational effects of 
cocaine (Robinson and Berridge 1993; 2000b). Besides that, a third, but not exclusively, 
hypothesis considers the effect of progesterone on changes in DA neurotransmission 
associated with the development of behavioral sensitization. This study does support the 
idea that progesterone may antagonize the facilitory effect of estradiol on self-
administration by antagonizing psychomotor sensitization. A study conducted by Peris 
and her colleges (Peris et al. 1991) have similar finding. OVX rats that received chronic 
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estradiol and progesterone administration had less cocaine-induced stereotyped and 
locomotor behaviors and lower AMPH-stimulated DA release from striatal slices in vitro 
than OVX rats that received estradiol alone. However, there are also some studies which 
showed that concurrent treatment of estrogen and progesterone results in greater cocaine-
induced behavior. The OVX rats implanted with silastic capsules containing estrogen plus 
progesterone showed greater magnitude of cocaine conditioned place preference and 
increased DA levels in the NAc (Russo et al. 2003a). Sell and her colleagues also found 
that hormone replacement with E+P in OVX rats resulted in greater cocaine-evoked 
hyperactivity than OVX animals (Sell et al. 2000). But the procedures used in those 
studies, which implant rats with silastic capsules that continuingly release estrogen and 
progesterone, are different from what we used here. Because of the different procedure, 
the hormone doses that have been released would probably different from the dose of 
injection in our study.  
    It is also possible that the continuous release of estrogen primed the rats before 
progesterone exerts its effect. The hypothesis that estrogen primes progesterone can be 
supported by our observation that when progesterone were given after treatment of 
estradiol for three days, cocaine induced rotational behavior were greatly enhanced 
compared to the OVX, the OVX+P, the concurrent E+P groups. This result indicates that 
progesterone modulates the effect of estradiol in different ways depending on how they 
are administered. It is in consistent with a previous report, which demonstrated that 
estrogen primed OVX rats with acute administration of progesterone had higher counts of 
locomotor activity in response to chronic cocaine than did vehicle control or 
progesterone-treated OVX rats (Perrotti et al. 2001). They also reported that cocaine 
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induced ambulatory and rearing activity peaked only when progesterone was 
administered 24 hr after estrogen and, more importantly, this effect does not correlate 
with the temporal interaction between estrogen and progesterone in the regulation of 
cocaine metabolism and HPA activation (Perrotti et al. 2003). Thus, a more proper 
explanation is progesterone interacts with estradiol to modulate nigrastriatal DA function.  
    Dluzen and his colleagues (Dluzen and Ramirez 1984) found that direct infusion of 
progesterone into superfusion chambers containing corpus striatum tissue fragments of 
estrogen primed ovariectomized female rats augmented spontaneous and AMPH-
stimulated DA release in vitro. This effect can be also demonstrated in castrated male rats 
pretreated with estrogen (Dluzen and Ramirez 1990a). Becker (Becker and Rudick 1999) 
also reported that acute progesterone injection after three days of EB treatment resulted in 
a significant enhancement both on AMPH induced stereotyped behaviors and striatal DA 
release during microdialysis. The effect of progesterone was very rapid and the 
significant increases in DA release occurred at 30 min post-progesterone (Dluzen and 
Ramirez 1990b). In addition, a membrane associated protein, which showed highly 
affinity for progesterone, was also found in striatum after estrogen priming (Ke and 
Ramirez 1990; Tischkau and Ramirez 1993). Until now, there is no evidence showing 
that the effect of progesterone on striatal DA release can be observed without estrogen 
priming. That may explain why we did not observe the increased behavioral sensitization 
when estrogen and progesterone were given concurrently.  
Finally, how estradiol and progesterone work together to modulate DA function is 
not clear at this moment. The effect of progesterone upon DA release is thought to 
happen through interneurons within the striatum rather than direct interaction with 
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DArgic nerve terminals (Dluzen and Ramirez 1989a). Medium spiny GABAergic 
neurons in the striatum could be one target that influenced directly by estradiol and 
progesterone, which then modulate DA system because estradiol was shown to rapidly 
inhibit KCl stimulated GABA outflow in striatum from a microdialysis study (Hu et al. 
2006).  
One interesting finding is that saline groups also got sensitized; although to a very 
limited extend to saline. They had similar response to cocaine on challenge day as 
cocaine groups. One possible reason might be the stress brought by handling and 
injection. Stress has long shown to influence psychomotor DA system (Piazza et al. 1990). 
Cross sensitization of stress and cocaine has also been described a lot (Kikusui et al. 
2005; Prasad et al. 1995; Prasad et al. 1998; Sorg 1992). In this study, each rats got three 
injections per day in the rotometer, which could cause a lot of stress.  
    Inherent sex differences in brain organization during development and the sex 
difference in the effect of circulating hormones both contribute to the gender differences 
in cocaine abuse that is observed. In regarding the effect of hormones, we should keep in 
mind that different hormone may not separately involved. The temporal/bimodal 
interaction between estradiol and progesterone in modulating behavioral response to 
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